Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 40
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Correction: Feasibility study of a SiPM-fiber detector for non-invasive measurement of arterial input function for preclinical and clinical positron emission tomography

  • de Scals, Sara
  • Fraile Prieto, Luis Mario
  • Udías Moinelo, José Manuel
  • Cortés, Laura Martínez
  • Oteo, Marta
  • Morcillo, Miguel Ángel
  • Carreras-Delgado, José Luis
  • Carreras Delgado, José Luis
  • Cabrera Martín, María Nieves
  • España Palomares, Samuel
Correction: EJNMMI Phys11, 12 (2024). https://doi.org/10.1186/s40658-024-00618-2 Following publication of the original article [1], the authors requested to update the Funding section. The original Funding sections was: This work was funded by the Universidad Complutense de Madrid under Project PR27/21 − 009 and by the Ministerio de Ciencia e Innovación under Project TED2021-129933B-C21. S. España is supported by the Ministerio de Ciencia, Innovación y Universidades under Ayudas Ramón y Cajal RYC2018-024495-I. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the MCIN and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (Grant CEX2020-001041-S funded by MICIN/AEI/https://doi.org/10.13039/501100011033). The correct Funding section should read: This work is part of the Project TED2021-129933B-C21 funded by the MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/ PRTR as well as by the Universidad Complutense de Madrid under Project PR27/21-009. S. España is supported by the Ministerio de Ciencia, Innovación y Universidades under Ayudas Ramón y Cajal RYC2018-024495-I. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the MCIN and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (Grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033). The original article [1] has been updated.
Docta Complutense
Publicación Artículo científico (JournalArticle)

BET inhibitor nanotherapy halts kidney damage and reduces chronic kidney disease progression after ischemia-reperfusion injury

  • Saiz, M. L.
  • Lozano-Chamizo, L.
  • Florez, A. B.
  • Marciello, Marzia
  • Diaz-Bulnes, P.
  • Corte-Iglesias, V.
  • Bernet, C. R.
  • Rodrigues-Diez, R. R.
  • Martin-Martin, C.
  • Rodriguez-Santamaria, M.
  • Fernandez-Vega, I.
  • Rodriguez, R. M.
  • Diaz-Corte, C.
  • Suarez-Alvarez, B.
  • Filice, Marco
  • Lopez-Larrea, C.
Targeting epigenetic mechanisms has emerged as a potential therapeutic approach for the treatment of kidney diseases. Specifically, inhibiting the bromodomain and extra-terminal (BET) domain proteins using the small molecule inhibitor JQ1 has shown promise in preclinical models of acute kidney injury (AKI) and chronic kidney disease (CKD). However, its clinical translation faces challenges due to issues with poor pharmacokinetics and side effects. Here, we developed engineered liposomes loaded with JQ1 with the aim of enhancing kidney drug delivery and reducing the required minimum effective dose by leveraging cargo protection. These liposomes efficiently encapsulated JQ1 in both the membrane and core, demonstrating superior therapeutic efficacy compared to freely delivered JQ1 in a mouse model of kidney ischemia-reperfusion injury. JQ1-loaded liposomes (JQ1-NPs) effectively targeted the kidneys and only one administration, one-hour after injury, was enough to decrease the immune cell (neutrophils and monocytes) infiltration to the kidney—an early and pivotal step to prevent damage progression. By inhibiting BRD4, JQ1-NPs suppress the transcription of pro-inflammatory genes, such as cytokines (il-6) and chemokines (ccl2, ccl5). This success not only improved early the kidney function, as evidenced by decreased serum levels of BUN and creatinine in JQ1-NPs-treated mice, along with reduced tissue expression of the damage marker, NGAL, but also halted the production of extracellular matrix proteins (Fsp-1, Fn-1, α-SMA and Col1a1) and the fibrosis development. In summary, this work presents a promising nanotherapeutic strategy for AKI treatment and its progression and provides new insights into renal drug delivery.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Titin domains with reduced core hydrophobicity cause dilated cardiomyopathy

  • Martínez-Martín, Inés
  • Crousilles, Audrey
  • Ochoa, Juan Pablo
  • Velázquez-Carreras, Diana
  • Mortensen, Simon A.
  • Herrero-Galán, Elías
  • Delgado Blanco, Javier
  • Domínguez, Fernando
  • García-Pavía, Pablo
  • Sancho, David de
  • Wilmanns, Matthias
  • Alegre-Cebollada, Jorge
The underlying genetic defect in most cases of dilated cardiomyopathy (DCM), a common inherited heart disease, remains unknown. Intriguingly, many patients carry single missense variants of uncertain pathogenicity targeting the giant protein titin, a fundamental sarcomere component. To explore the deleterious potential of these variants, we first solved the wild-type and mutant crystal structures of I21, the titin domain targeted by pathogenic variant p.C3575S. Although both structures are remarkably similar, the reduced hydrophobicity of deeply buried position 3575 strongly destabilizes the mutant domain, a scenario supported by molecular dynamics simulations and by biochemical assays that show no disulfide involving C3575. Prompted by these observations, we have found that thousands of similar hydrophobicity-reducing variants associate specifically with DCM. Hence, our results imply that titin domain destabilization causes DCM, a conceptual framework that not only informs pathogenicity assessment of gene variants but also points to therapeutic strategies counterbalancing protein destabilization., J.A.-C. acknowledges funding from the Ministerio de Ciencia e Innovación (MCIN, MCIN/AEI/10.13039/501100011033) through grants BIO2017-83640-P (AEI/FEDER, EU), PID2020-120426GB-I00, and RED2022-134242-T and the Regional Government of Madrid (grant Tec4Bio S2018/NMT-4443, 50% co-financed by the European Social Fund and the European Regional Development Fund for the programming period 2014–2020). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the MCIN, and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MCIN). I.M.-M. holds a fellowship from 'la Caixa' Foundation (ID 100010434, fellowship code LCF/BQ/DR20/11790009) and received support from a Erasmus + Training fellowship. Financial support to D.d.S. comes from Eusko Jaurlaritza (Basque Government) through the project IT1584-22 and from the MCIN through grants PID2021-127907NB-I00 (AEI/FEDER, UE) and RYC-2016-19590 (AEI/FSE, EU). We thank Maria Rosaria Pricolo for analysis support with database analysis, Vytautas Gapsys for his assistance using the pmx software package, and the staff at the DIPC Supercomputing Center and the Sample Preparation and Characterization facility of the EMBL Hamburg Unit for technical support. The synchrotron data were collected at beamline operated by EMBL Hamburg at the PETRA III storage ring (DESY, Hamburg, Germany). We thank the Spectroscopy and Nuclear Magnetic Resonance Core Unit at CNIO for access to CD instrumentation. Biorender.com was used as a source for icons included in some of the figures of this paper.
Repisalud
Publicación Artículo científico (JournalArticle)

Imidazole propionate is a driver and therapeutic target in atherosclerosis.

  • Mastrangelo, Annalaura
  • Robles-Vera, Iñaki
  • Mañanes, Diego
  • Galán, Miguel
  • Femenía-Muiña, Marcos
  • Redondo-Urzainqui, Ana
  • Barrero-Rodríguez, Rafael
  • Papaioannou, Eleftheria
  • Amores-Iniesta, Joaquín
  • Devesa, Ana
  • Lobo-González, Manuel
  • Carreras, Alba
  • Beck, Katharina R
  • Ivarsson, Sophie
  • Gummesson, Anders
  • Georgiopoulos, Georgios
  • Rodrigo-Tapias, Manuel
  • Martínez-Cano, Sarai
  • Fernández-López, Ivan
  • Nuñez, Vanessa
  • Ferrarini, Alessia
  • Inohara, Naohiro
  • Stamatelopoulos, Kimon
  • Benguría, Alberto
  • Cibrian, Danay
  • Sánchez-Madrid, Francisco
  • Alonso-Herranz, Vanesa
  • Dopazo, Ana
  • Barbas, Coral
  • Vázquez, Jesús
  • López, Juan Antonio
  • González-Martín, Alicia
  • Nuñez, Gabriel
  • Stellos, Konstantinos
  • Bergström, Göran
  • Bäckhed, Fredrik
  • Fuster, Valentín
  • Ibañez, Borja
  • Sancho, David
Atherosclerosis is the main underlying cause of cardiovascular diseases. Its prevention is based on the detection and treatment of traditional cardiovascular risk factors. However, individuals at risk for early vascular disease often remain unidentified. Recent research has identified new molecules in the pathophysiology of atherosclerosis, highlighting the need for alternative disease biomarkers and therapeutic targets to improve early diagnosis and therapy efficacy. Here, we observed that imidazole propionate (ImP), produced by microorganisms, is associated with the extent of atherosclerosis in mice and in two independent human cohorts. Furthermore, ImP administration to atherosclerosis-prone mice fed with chow diet was sufficient to induce atherosclerosis without altering the lipid profile, and was linked to activation of both systemic and local innate and adaptive immunity and inflammation. Specifically, we found that ImP caused atherosclerosis through the imidazoline-1 receptor (I1R, also known as nischarin) in myeloid cells. Blocking this ImP-I1R axis inhibited the development of atherosclerosis induced by ImP or high-cholesterol diet in mice. Identification of the strong association of ImP with active atherosclerosis and the contribution of the ImP-I1R axis to disease progression opens new avenues for improving the early diagnosis and personalized therapy of atherosclerosis.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Organotin(IV)-Decorated Graphene Quantum Dots as Dual Platform for Molecular Imaging and Treatment of Triple Negative Breast Cancer

  • Gómez Pérez, Inmaculada Jénnifer
  • Ovejero, Karina
  • Méndez-Arriaga, José M.
  • Pizurova, Nada
  • Filice, Marco
  • Zajickova, Lenka
  • Prashar, Sanjiv
  • Gómez-Ruiz, Santiago
[ Abstract] The pharmacological activity of organotin(IV) complexes in cancer therapy is well recognized but their large applicability is hampered by their poor water solubility. Hence, carbon dots, in particular nitrogen-doped graphene quantum dots (NGQDs), may be a promising alternative for the efficient delivery of organotin(IV) compounds as they have a substantial aqueous solubility, a good chemical stability, and non-toxicity as well as a bright photoluminescence that make them ideal for theranostic applications against cancer. Two different multifunctional nanosystems have been synthesized and fully characterized based on two fragments of organotin-based cytotoxic compounds and 4-formylbenzoic acid (FBA), covalently grafted onto the NGQDs surface. Subsequently, an in vitro determination of the therapeutic and theranostic potential of the achieved multifunctional systems was carried out. The results showed a high cytotoxic potential of the NGQDs-FBA-Sn materials against breast cancer cell line (MDA-MB-231) and a lower effect on a non-cancer cell line (kidney cells, HEK293T). Besides, thanks to their optical properties, the dots enabled their fluorescence molecular imaging in the cytoplasmatic region of the cells pointing towards a successful cellular uptake and a release of the metallodrug inside cancer cells (NGQDs-FBA-Sn)., This work was supported by Operational Program Research, Development, and Education-Project ‘MSCAfellow4@MUNI’ (No. CZ.02.2.69/0.0/0.0/20_079/0017045) and the Spanish Ministry of Universities for a Maria Zambrano funding (RSU.UDC.MZ09 [RSU.UDC.MZ11]) transferred by the European Union-Next Generation EU. We acknowledge CzechNanoLab Research Infrastructure (LM2018110), supported by the Ministry of Education, Youth and Sports of the Czech Republic (MEYS CR). We are grateful to Prof. Vladimír Šindelář and Prof. Petr Klan for allowing us to use the MW reactor, UV-vis and fluorescence spectrometer, supported by RECETOX research infrastructure (via MEYS CR under LM2018121). M.F. is grateful to Instituto de Salud Carlos III (ISCIII) for project No DTS20/00109 (AES20-ISCIII) and PI22/00789 (AES22-ISCIII). M.F. and K.O.P. acknowledge the support of Microscopy & Dynamic Imaging Unit of CNIC, Madrid, Spain. The Unit is part of the ReDiB-ICTS and has the support of FEDER, “Una manera de hacer Europa.” The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033). We would also like to thank funding from the research project PID2022-136417NB-I00 financed by MCIN/AEI/10.13039/501100011033/ and “ERDF A way of making Europe”, and from the Research Thematic Network RED2022-134091-T financed by MCIN/AEI/10.13039/501100011033., Česká republika. Ministerstvo školství, mládeže a tělovýchovy České republiky; LM2018110, Česká republika. RECETOX; LM2018121
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Neutrophil β1 adrenergic receptor blockade blunts stroke-associated neuroinflammation

  • Clemente-Moragón, Agustín
  • Oliver, Eduardo
  • Calle, D.
  • Cussó, Lorena
  • Gómez Tech, Mónica
  • Pradillo, Jesús M.
  • Castejón, Raquel
  • Rallón, Norma
  • Benito, José Miguel
  • Fernández-Ferro, José C.
  • Carneado-Ruíz, Joaquín
  • Moro, María A.
  • Sánchez-González, Javier
  • Fuster, Valentín
  • Cortés-Canteli, Marta
  • Desco, Manuel
  • Ibáñez, Borja
39 p.-7 fig.-1 graph. abst., Background and Purpose Reperfusion therapy is the standard of care for ischemic stroke; however, there is a need to identify new therapeutic targets able to ameliorate cerebral damage. Neutrophil´s β1 adrenergic receptor (β1AR) has been linked to migration during exacerbated inflammation. Given the central role of neutrophils in cerebral damage during stroke, we hypothesize that β1AR blockade will improve stroke outcomes., Experimental Approach Rats were subjected to middle cerebral artery occlusion–reperfusion to evaluate the effect on stroke of the selective β1AR blocker metoprolol (12.5 mg/Kg) when injected i.v. 10 min before reperfusion., Key Results Magnetic resonance imaging and histopathology analysis showed that pre-reperfusion i.v. metoprolol reduced IS. This was accompanied by reduced cytotoxic edema at 24 h and vasogenic edema at 7 d. Metoprolol-treated rats showed reduced brain neutrophil infiltration and those which infiltrated displayed a high proportion of anti-inflammatory phenotype (N2, YM1+). Additional inflammatory models demonstrated that metoprolol specifically blocked neutrophil migration via β1AR and excluded a significant effect on glia compartment. Consistently, metoprolol did not protect the brain in neutrophil-depleted rats upon stroke. In patients suffering an ischemic stroke, β1AR blockade by metoprolol reduced circulating neutrophil–platelet co-aggregates., Conclusions and Implications Our findings describe that β1AR blockade ameliorates cerebral damage by targeting neutrophils, identifying a novel therapeutic target to improve outcomes in patients with stroke. This therapeutic strategy is in the earliest stages of the translational pathway and should be further explored., This study received funding from the Instituto de Salud Carlos III (ISCIII; PI16/02110 to B.I and PT20/00044 to MD), the European Regional Development Fund (ERDF) “A way of making Europe", the Comunidad de Madrid (S2017/BMD-3867 RENIM-CM to MD and BI) cofunded with European structural and investment funds and by Agencia Estatal de Investigación (PID2019‐110369RB‐I00 to B.I). BI is a recipient of funding from the European Research Council (ERC) under the European Union Horizon 2020 Research and Innovation Programme (ERC-Consolidator Grant agreement No. 819775). EO is a recipient of funds from the Comunidad de Madrid Programa de Atracción de Talento (2017-T1/BMD 5185) and from a Ramón y Cajal grant (RYC2020-028884-I) funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”. ACM is the beneficiary of an FPU fellowship from the Ministerio de Ciencia e Innovación (FPU2017/01932). MCC is the beneficiary of a Miguel Servet contract (MS16/00174). The CNIC is supported by the ISCIII, the Ministerio de Ciencia e Innovación and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (CEX2020-001041-S)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2020-001041-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

End-binding protein 1 regulates the metabolic fate of CD4+ T lymphoblasts and Jurkat T cells and the organization of the mitochondrial network

  • Gómez-Morón, Álvaro
  • Requena, Silvia
  • Pertusa, Clara
  • Lozano-Prieto, Marta
  • Calzada-Fraile, Diego
  • Scagnetti, Camila
  • Sánchez-García, Inés
  • Calero-García, Ana Adela
  • Izquierdo, Manuel
  • Martín-Cófreces, Noa B.
The organization of the mitochondrial network is relevant for the metabolic fate of T cells and their ability to respond to TCR stimulation. This arrangement depends on cytoskeleton dynamics in response to TCR and CD28 activation, which allows the polarization of the mitochondria through their change in shape, and their movement along the microtubules towards the immune synapse. This work focus on the role of End-binding protein 1 (EB1), a protein that regulates tubulin polymerization and has been previously identified as a regulator of intracellular transport of CD3-enriched vesicles. EB1-interferred cells showed defective intracellular organization and metabolic strength in activated T cells, pointing to a relevant connection of the cytoskeleton and metabolism in response to TCR stimulation, which leads to increased AICD. By unifying the organization of the tubulin cytoskeleton and mitochondria during CD4+ T cell activation, this work highlights the importance of this connection for critical cell asymmetry together with metabolic functions such as glycolysis, mitochondria respiration, and cell viability., This study was supported by grants S2022/BMD-7209-INTEGRAMUNE-CM to NBMC from the Madrid Regional Government, PDC2021-121719-I00 and PLEC2022-009298 (AEI/FEDER, UE) from the Spanish Ministry of Economy and Competitiveness (MINECO). Work in the MI lab is funded by grant PID2020-114148RB-I00 from the Spanish Ministry of Science and Innovation MCIN/AEI/ 10.13039/501100011033, which was in part granted with FEDER funding (EC). CIBER Cardiovascular (Fondo de Investigación Sanitaria del Instituto de Salud Carlos III and co-funding by Fondo Europeo de Desarrollo Regional FEDER). ÁG-M is supported by an Investigo Grant by SEPE (Fondos de Resiliencia), Gobierno de España. SR is supported by a Sara Borrell fellowship from ISCIII and DC-F is supported by a fellowship from “la Caixa” Foundation (LCF/BQ/DR19/11740010). CS is supported by PEJ-2021-TL/BMD-21204 “Garantía Juvenil” grant form Comunidad de Madrid. ML-P is a FPI fellowship (PRE2021-097478) from the Spanish Ministry of Science and Innovation. The Centro Nacional de Investigaciones Cardiovasculares (CNIC) is supported by the ISCIII, the Ministerio de Ciencia e Innovación and the Pro CNIC Foundation. The CNIC is a Severo Ochoa Center of Excellence (MINECO award CEX2020-001041-S)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2020-001041-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

γ-Linolenic acid in maternal milk drives cardiac metabolic maturation

  • Paredes, Ana
  • Justo-Méndez, Raquel
  • Jimenez-Blasco, Daniel
  • Núñez, Vanessa
  • Calero, Irene
  • Villalba-Orero, María
  • Alegre-Martí, Andrea
  • Fischer, Thierry
  • Gradillas, Ana
  • Rodrigues Sant’Anna, Viviane Aparecida
  • Were, Felipe
  • Huang, Zhiqiang
  • Hernansanz-Agustín, Pablo
  • Contreras, Carmen
  • Martínez, Fernando
  • Camafeita, Emilio
  • Vázquez, Jesús
  • Ruiz-Cabello, Jesús
  • Area-Gomez, Estela
  • Sánchez-Cabo, Fátima
  • Treuter, Eckardt
  • Bolaños, Juan P.
  • Estébanez-Perpiñá, Eva
  • Rupérez, Francisco Javier
  • Barbas, Coral
  • Enríquez, José Antonio
  • Ricote, M. Mercedes
Birth presents a metabolic challenge to cardiomyocytes as they reshape fuel preference from glucose to fatty acids for postnatal energy production. This adaptation is triggered in part by post-partum environmental changes, but the molecules orchestrating cardiomyocyte maturation remain unknown. Here we show that this transition is coordinated by maternally supplied γ-linolenic acid (GLA), an 18:3 omega-6 fatty acid enriched in the maternal milk. GLA binds and activates retinoid X receptors (RXRs), ligand-regulated transcription factors that are expressed in cardiomyocytes from embryonic stages. Multifaceted genome-wide analysis revealed that the lack of RXR in embryonic cardiomyocytes caused an aberrant chromatin landscape that prevented the induction of an RXR-dependent gene expression signature controlling mitochondrial fatty acid homeostasis. The ensuing defective metabolic transition featured blunted mitochondrial lipid-derived energy production and enhanced glucose consumption, leading to perinatal cardiac dysfunction and death. Finally, GLA supplementation induced RXR-dependent expression of the mitochondrial fatty acid homeostasis signature in cardiomyocytes, both in vitro and in vivo. Thus, our study identifies the GLA–RXR axis as a key transcriptional regulatory mechanism underlying the maternal control of perinatal cardiac metabolism., The authors thank the members of the M.R. and J.A.E laboratories, A. Hidalgo and M. Torres for extensive discussions of the paper; G. Sabio, N. Rochel and D. Metzger for mice and reagents; CNIC and CRG Genomics Units for sequencing; S. Bartlett for editorial assistance; and A.V. Alonso, L. Flores, R. Baeza, R. Santos-Clemente, C. Gifford and N. Spann for technical assistance. J.P.B. is funded by the NextGenerationEU/PRTR and Agencia Estatal de Investigación (10.13039/501100011033; PID2019-105699RB-I00; PDC2021-121013-I00, RED2018-102576-T), Instituto de Salud Carlos III (CB16/10/00282), and Junta de Castilla y León (Apoyo Regional a la Competitividad Empresarial, ICE 04/18/LE/0017 and Escalera de Excelencia CLU-2017-03). D.J.-B. And P.H.A. are recipients of a Juan de la Cierva-Incorporación contracts (IJC2020-044230-I and IJC2020-042679-I, respectively). F.J.R. is funded by the Ministerio de Ciencia e Innovación (MCIN) and European Regional Development Fund FEDER (PID2021- 122490NB-I00). V.A.R.S. received funding from Airbus Defense and Space through the CLX-2 programme in partnership with Comando da Aeronautica (COMAER) and the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil (CAPES). E.T. received funding from the Swedish Research Council (2020-01150), the Swedish Cancer Society (211582), and the Novo Nordisk Foundation (NNF20OC0063672). J.A.E. was supported by RTI2018-099357-B-I00, MCIU/AEI/ ERDF/UE; RTI2018-099357-B-I00 MCIU/AEI; PID2021-1279880B-100 MCIN/AEI/ 10.13039/501100011033/ERDF,UE; CB16/10/00282 CIBERFES and 17CVD04 Foundation Leducq. This work was supported by grants to M.R.: SAF2017-90604-REDT-NurCaMeIn MINECO/AEI; RTI2018-095928-BI00, MCIU/AEI/ ERDF/UE; PID2021-122552OB-I00 MCIN/AEI/ 10.13039/501100011033/ERDF,UE; 201605-32 Fundació La Marató de TV3; and S2017/BMD- 3684 Comunidad de Madrid/ESF/EU, S2022/BMD-7227 Comunidad de Madrid; and an MINECO fellowship to A.P. (BES-2016-076632/AEI/ESF) and to R.J.-M. (PRE2019-087462). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN), and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/ AEI/ 10.13039/501100011033)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Atherosclerotic plaque development in mice is enhanced by myeloid ZEB1 downregulation

  • Martinez-Campanario, M. C.
  • Cortés, Marlies
  • Moreno-Lanceta, Alazne
  • Han, Lu
  • Ninfali, Chiara
  • Domínguez, Verónica
  • Andrés-Manzano, María J.
  • Farràs, Marta
  • Esteve-Codina, Anna
  • Enrich, Carlos
  • Díaz-Crespo, Francisco J.
  • Pintado, Belén
  • Escolà-Gil, Joan Carles
  • García de Frutos, Pablo
  • Andrés, Vicente
  • Melgar-Lesmes, Pedro
  • Postigo, Antonio
Accumulation of lipid-laden macrophages within the arterial neointima is a critical step in atherosclerotic plaque formation. Here, we show that reduced levels of the cellular plasticity factor ZEB1 in macrophages increase atherosclerotic plaque formation and the chance of cardiovascular events. Compared to control counterparts (Zeb1 /Apoe ), male mice with Zeb1 ablation in their myeloid cells (Zeb1 /Apoe ) have larger atherosclerotic plaques and higher lipid accumulation in their macrophages due to delayed lipid traffic and deficient cholesterol efflux. Zeb1 /Apoe mice display more pronounced systemic metabolic alterations than Zeb1 /Apoe mice, with higher serum levels of low-density lipoproteins and inflammatory cytokines and larger ectopic fat deposits. Higher lipid accumulation in Zeb1 macrophages is reverted by the exogenous expression of Zeb1 through macrophage-targeted nanoparticles. In vivo administration of these nanoparticles reduces atherosclerotic plaque formation in Zeb1 /Apoe mice. Finally, low ZEB1 expression in human endarterectomies is associated with plaque rupture and cardiovascular events. These results set ZEB1 in macrophages as a potential target in the treatment of atherosclerosis., IDIBAPS is partly funded by the Generalitat of Catalonia’s CERCA Programme. The studywas conducted at the IDIBAPS’ Centre de Recerca Biomèdica Cellex building,which was partly funded by the Cellex Foundation. The different parts of this study were independently funded by grants to A.P. from the Catalan Agency forManagement of University and Research Grants (AGAUR) (2021-SGR- 01328), and Spanish State Research Agency (AEI) (PID2020-116338RBI00) of the Ministry of Science and Innovation (MICINN), as part of the 2021–2023 Plan for Scientific and Technical Research and Innovation (PEICTI), which is co-financed by the European Regional Development Fund (ERDF) of the European Union Commission. A.M.-L. is a recipient of a PhD scholarship from MICINN (FPI Program) (PRE2019-088097). A.E.- C’s salary is covered by grant PT17/0009/0019 from Carlos III Spanish Health Institute (ISCIII, co-funded by the ERDF) to CNAG. CNIC is supported by MCINN, ISCIII, the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (CEX2020-001041-S funded by MCIN/AEI/ 10.13039/501100011033). P.M.-L. salary is supported by a fellowship from AEI’s Ramon y Cajal Program (RYC2018-0Z23971-I). L.H. is supported by a PhD scholarship from the China Scholarship Council (202208110041)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001041-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

ICAMs in Immunity, Intercellular Adhesion and Communication

  • Guerra-Espinosa, Claudia
  • Jiménez-Fernández, María
  • Sánchez-Madrid, Francisco
  • Serrador, Juan M.
Interactions among leukocytes and leukocytes with immune-associated auxiliary cells represent an essential feature of the immune response that requires the involvement of cell adhesion molecules (CAMs). In the immune system, CAMs include a wide range of members pertaining to different structural and functional families involved in cell development, activation, differentiation and migration. Among them, β2 integrins (LFA-1, Mac-1, p150,95 and αDβ2) are predominantly involved in homotypic and heterotypic leukocyte adhesion. β2 integrins bind to intercellular (I)CAMs, actin cytoskeleton-linked receptors belonging to immunoglobulin superfamily (IgSF)-CAMs expressed by leukocytes and vascular endothelial cells, enabling leukocyte activation and transendothelial migration. β2 integrins have long been viewed as the most important ICAMs partners, propagating intracellular signalling from β2 integrin-ICAM adhesion receptor interaction. In this review, we present previous evidence from pioneering studies and more recent findings supporting an important role for ICAMs in signal transduction. We also discuss the contribution of immune ICAMs (ICAM-1, -2, and -3) to reciprocal cell signalling and function in processes in which β2 integrins supposedly take the lead, paying particular attention to T cell activation, differentiation and migration., This study was supported by grant PID2022-140155OB-I00 to J.M.S. and grants PDC2021- 121719-I00 and PID-2020-120412RB-I00 to F.S.M. from the Spanish Ministry of Science, Innovation and Universities, and also supported by grants S2022/BMD-7209 (INTEGRAMUNE-CM) and by “La Caixa” Health Research Grant LCF/PR/HR23/52430018. C.G-E. was supported by Unión Europea—Next Generation EU. M.J-F. was supported by Formación Personal Investigador Severo Ochoa (FPI-SO) Program (PRE2019-087941), Ministry of Science, Innovation and Universities and Fondo Europeo de Desarrollo Regional (FEDER) and Fondo Social Europeo (FSE). The CBMSO receives an institutional grant from the Fundación Ramón Areces. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation. The CBMSO and the CNIC are both Severo Ochoa Center of Excellence (grant CEX2021-001154-S and grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001154-S)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001041-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Defensive-lipid droplets: Cellular organelles designed for antimicrobial immunity

  • Safi, Rémi
  • Sánchez-Álvarez, Miguel
  • Bosch, Marta
  • Demangel, Caroline
  • Parton, Robert G.
  • Pol, Albert
Microbes have developed many strategies to subvert host organisms, which, in turn, evolved several innate immune responses. As major lipid storage organelles of eukary-otes, lipid droplets (LDs) are an attractive source of nutrients for invaders. Intracellular viruses, bacteria, and protozoan parasites induce and physically interact with LDs, and the current view is that they “hijack” LDs to draw on substrates for host colonization. This dogma has been challenged by the recent demonstration that LDs are endowed with a protein- mediated antibiotic activity, which is upregulated in response to danger signals and sepsis. Dependence on host nutrients could be a generic “Achilles’ heel” of intracellular pathogens and LDs a suitable chokepoint harnessed by innate immunity to organize a front- line defense. Here, we will provide a brief overview of the state of the conflict and discuss potential mechanisms driving the formation of the ‘defensive- LDs’ functioning as hubs of innate immunity., RS is recipient of the Lady Tata Memorial Trust grant for leukemia research and the Marie Skłodowska-Curie Actions Postdoctoral Fellowship (MSCA-PF) granted by the European commission. MS-A is recipient of a Ramón y Cajal researcher contract and a research grant from the Spanish Ministerio de Innovación y Ciencia (RYC2020-029690 and PID2021-128106NA-I00). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the MCIN and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033). AP and MB are supported by I+D+i RETOS INVESTIGACIÓN from the Ministerio de Ciencia e Investigación (MICINN, PID2021-127043OB-I00) and the CERCA Programme/Generalitat de Catalunya. AP is supported by the H2020-MSCA-ITN-2018, 953489 (ENDOCONNECT). RGP is a Laureate Fellow of the Australian Research Council. AP, RGP, and CD are supported by the ERC Synergy Grant ERC-2022-SYG, 101071784 (DRIMMS). Figures were generated using Adobe Photoshop (Adobe), Powerpoint (Microsoft), Graphpad Prism (Dotmatics), and BioRender., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001041-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Remodeling arteries: studying the mechanical properties of 3D-bioprinted hybrid photoresponsive materials

  • Aizarna-Lopetegui, Uxue
  • García-Astrain, Clara
  • Renero-Lecuna, Carlos
  • González-Callejo, Patricia
  • Villaluenga, Irune
  • Pozo, Miguel Angel
  • Sánchez-Álvarez, Miguel
  • Henriksen-Lacey, Malou
  • Jimenez de Aberasturi, Dorleta
3D-printed cell models are currently in the spotlight of medical research. Whilst significant advances have been made, there are still aspects that require attention to achieve more realistic models which faithfully represent the in vivo environment. In this work we describe the production of an artery model with cyclic expansive properties, capable of mimicking the different physical forces and stress factors that cells experience in physiological conditions. The artery wall components are reproduced using 3D printing of thermoresponsive polymers with inorganic nanoparticles (NPs) representing the outer tunica adventitia, smooth muscle cells embedded in extracellular matrix representing the tunica media, and finally a monolayer of endothelial cells as the tunica intima. Cyclic expansion can be induced thanks to the inclusion of photo-responsive plasmonic NPs embedded within the thermoresponsive ink composition, resulting in changes in the thermoresponsive polymer hydration state and hence volume, in a stimulated on–off manner. By changing the thermoresponsive polymer composition, the transition temperature and pulsatility can be efficiently tuned. We show the direct effect of cyclic expansion and contraction on the overlying cell layers by analyzing transcriptional changes in mechanoresponsive mesenchymal genes associated with such microenvironmental physical cues. The technique described herein involving stimuli-responsive 3D printed tissue constructs, also described as four- dimensional (4D) printing, offers a novel approach for the production of dynamic biomodels., Financial support is acknowledged from the MCIN/AEI/10.13039/501100011033 through grant # PID2019-108854RA-I00. C. G. A. thanks to the Ministerio de Ciencia e Innovación (MCIN) for a Juan de la Cierva Incorporación Fellowship (IJC2019-040827-I). M. S.-A. is recipient of a Ramón y Cajal contract and a “Generación de Conocimiento” grant from the Ministerio de Ciencia e Innovación (RYC2020-029690-I and PID2021-128106NA-I00). MAdP is coordinator and PL of “AtheroConvergence” La Caixa Foundation Health Research consortium (HR20-00075). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the MCIN and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S). We acknowledge ALBA for provision of synchrotron radiation facilities. We would like to thank Dr Marc Malfois for assistance in using BL11-NCD beamline, and Unai Cossío and Daniel Padro for help with image analysis., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001041-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Microvesicles and inflammatory markers in an animal model of chronic postcapillary pulmonary hypertension

  • Mendoza-Zambrano, Elva María
  • Gómez-Rodríguez, Belén
  • García-Lunar, Inés
  • Pereda-Arnau, Daniel
  • Sánchez-López, Verónica
  • García-Álvarez, Ana
  • Otero Candelera, Remedios
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions., This work was supported by Carlos III Health Institute [PI11/02308]; Spanish Society of Pulmonology and Thoracic Surgery, SEPAR [124/2011]; Ministry of Economy, Innovation, Science and Employment of the Junta de Andalucía [CVI-6654/2010]; Ministry for Science and Innovation (MCIN) and Pro CNIC Foundation. The CNIC is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001041-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Oxidative Post-translational Protein Modifications upon Ischemia/Reperfusion Injury

  • Binek, Aleksandra
  • Castans, Celia
  • Jorge, Inmaculada
  • Bagwan, Navratan
  • Rodríguez, José Manuel
  • Fernández-Jiménez, Rodrigo
  • Galán-Arriola, Carlos
  • Oliver, Eduardo
  • Gómez, Mónica
  • Clemente-Moragón, Agustín
  • Ibáñez, Borja
  • Camafeita, Emilio
  • Vázquez, Jesús
While reperfusion, or restoration of coronary blood flow in acute myocardial infarction, is a requisite for myocardial salvage, it can paradoxically induce a specific damage known as ischemia/reperfusion (I/R) injury. Our understanding of the precise pathophysiological molecular alterations leading to I/R remains limited. In this study, we conducted a comprehensive and unbiased time-course analysis of post-translational modifications (PTMs) in the post-reperfused myocardium of two different animal models (pig and mouse) and evaluated the effect of two different cardioprotective therapies (ischemic preconditioning and neutrophil depletion). In pigs, a first wave of irreversible oxidative damage was observed at the earliest reperfusion time (20 min), impacting proteins essential for cardiac contraction. A second wave, characterized by irreversible oxidation on different residues and reversible Cys oxidation, occurred at late stages (6–12 h), affecting mitochondrial, sarcomere, and inflammation-related proteins. Ischemic preconditioning mitigated the I/R damage caused by the late oxidative wave. In the mouse model, the two-phase pattern of oxidative damage was replicated, and neutrophil depletion mitigated the late wave of I/R-related damage by preventing both Cys reversible oxidation and irreversible oxidation. Altogether, these data identify protein PTMs occurring late after reperfusion as an actionable therapeutic target to reduce the impact of I/R injury., This study was supported by competitive grants from the MCIN/AEI/10.13039/501100011033/ and FEDER Una manera de hacer Europa (PID2021-122348NB-I00 and PID2022-140176OB-I00), the MCIN/AEI/10.13039/501100011033 the Unión Europea NextGenerationEU/PRTR (PLEC2022-009235, and PLEC2022-009298), the Comunidad de Madrid (Programa S2022/BDM-7333-CM, INMUNO-VAR, P2022/BMD-7333, and RENIM-CM, P2022/BMD-7403), “la Caixa” Banking Foundation (HR17-00247, LCF/PR/HP22/52320018, and LCF/PR/HR22/52420019), and the European Commission (ERC Consolidator Grant “MATRIX”, 819775). Rodrigo Fernandez-Jimenez is the recipient of grant PI22/01560 funded by the ISCIII-Fondo de Investigación Sanitaria and co-funded by the European Union. Aleksandra Binek and Navratan Bagwan were FP7-PEOPLE-2013-ITN-Cardionext fellows from the European Union’s Seventh Framework Programme (Marie Curie Actions). Celia Castans holds a Formación del Profesorado Universitario (FPU14/05292) fellowship from the Spanish Ministry of Education, Culture and Sports. Eduardo Oliver holds a Ramón y Cajal fellowship (RYC2020-028884-I) and granted by the MCIN/AEI/10.13039/501100011033/ and FEDER Una manera de hacer Europa (PID2021-133167OB-100) and by “ESF Investing in your future”. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN), and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001041-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Oxidative phosphorylation selectively orchestrates tissue macrophage homeostasis

  • Wculek, Stefanie K
  • Heras-Murillo, Ignacio
  • Mastrangelo, Annalaura
  • Mañanes, Diego
  • Galán, Miguel
  • Miguel, Verónica
  • Curtabbi, Andrea
  • Barbas, Coral
  • Chandel, Navdeep S
  • Enríquez, José Antonio
  • Lamas Peláez, Santiago
  • Sancho, David
In vitro studies have associated oxidative phosphorylation (OXPHOS) with anti-inflammatory macrophages, whereas pro-inflammatory macrophages rely on glycolysis. However, the metabolic needs of macrophages in tissues (TMFs) to fulfill their homeostatic activities are incompletely understood. Here, we identified OXPHOS as the highest discriminating process among TMFs from different organs in homeostasis by analysis of RNA-seq data in both humans and mice. Impairing OXPHOS in TMFs via Tfam deletion differentially affected TMF populations. Tfam deletion resulted in reduction of alveolar macrophages (AMs) due to impaired lipid-handling capacity, leading to increased cholesterol content and cellular stress, causing cell-cycle arrest in vivo. In obesity, Tfam depletion selectively ablated pro-inflammatory lipid-handling white adipose tissue macrophages (WAT-MFs), thus preventing insulin resistance and hepatosteatosis. Hence, OXPHOS, rather than glycolysis, distinguishes TMF populations and is critical for the maintenance of TMFs with a high lipid-handling activity, including pro-inflammatory WAT-MFs. This could provide a selective therapeutic targeting tool., This project was supported by the “la Caixa” Foundation (ID 100010434) Postdoctoral Junior Leader Fellowship code LCF/BQ/PR20/11770008 (S.K.W.); “la Caixa” Foundation (ID 100010434) INPhINIT Fellowship code LCF/BQ/IN17/11620074 (I.H.-M.); Spanish Ministry of Education FPU fellowship code FPU20/01418 (M.G.); Ministerio de Ciencia e Innovación (MCIN) PID2019-104233RB-100/AEI/10.13039/501100011033 (S.L.); and NIH grants P01AG049665-08, RO1A148190, and P01HL154998 (N.S.C.). The J.A.E. laboratory is supported by the CNIC and a grant by Ministerio de Ciencia, Innovación y Universidades (MCNU); Agencia Estatal de Investigación (AEI) and Fondo Europeo de Desarrollo Regional (FEDER) (RTI2018-099357-B-I00); the Biomedical Research Networking Center on Frailty and Healthy Ageing (CIBERFES-ISCiii-CB16/10/00289); and the HFSP agency (RGP0016/2018). Work in the D.S. laboratory is funded by the CNIC; by the European Union’s Horizon 2020 research and innovation program under grant agreement ERC-2016-Consolidator grant 725091; by Spanish Ministerio de Ciencia e Innovación PID2019-108157RB/AEI/ and CPP2021-008310/AEI/10.13039/501100011033; by Comunidad de Madrid (P2022/BMD-7333 INMUNOVAR-CM); and by “la Caixa” Foundation (LCF/PR/HR20/00075 and LCF/PR/HR22/00253). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the MICINN, and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (CEX2020-001041-S funded by MCIN/AEI/10.13039/501100011033)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2020-001041-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling

  • Terri, Michela
  • Sandoval, Pilar
  • Bontempi, Giulio
  • Montaldo, Claudia
  • Tomero-Sanz, Henar
  • Turris, Valeria de
  • Trionfetti, Flavia
  • Pascual-Antón, Lucía
  • Clares, Irene
  • Battistelli, Cecilia
  • Valente, Sergio
  • Zwergel, Clemens
  • Mai, Antonello
  • Rosanò, Laura
  • Pozo, Miguel Angel
  • Sánchez-Álvarez, Miguel
  • Cabañas, Carlos
  • Tripodi, Marco
  • López-Cabrera, Manuel
  • Strippoli, Raffaele
[Background]: Peritoneal metastasis, which accounts for 85% of all epithelial ovarian carcinoma (EOC) metastases, is a multistep process that requires the establishment of adhesive interactions between cancer cells and the peritoneal membrane. Interrelations between EOC and the mesothelial stroma are critical to facilitate the metastatic process. No data is available so far on the impact of histone acetylation/deacetylation, a potentially relevant mechanism governing EOC metastasis, on mesothelial cells (MCs)-mediated adhesion., [Methods]: Static adhesion and peritoneal clearance experiments were performed pretreating mesenchymal-like MCs and platinum—sensitive/resistant EOC cell lines with MS-275—a Histone deacetylase (HDAC)1–3 pharmacological inhibitor currently used in combination trials. Results were acquired by confocal microscopy and were analyzed with an automated Opera software. The role of HDAC1/2 was validated by genetic silencing. The role of α4-, α5-α1 Integrins and Fibronectin-1 was validated using specific monoclonal antibodies. Quantitative proteomic analysis was performed on primary MCs pretreated with MS-275. Decellularized matrices were generated from either MS-275-exposed or untreated cells to study Fibronectin-1 extracellular secretion. The effect of MS-275 on β1 integrin activity was assessed using specific monoclonal antibodies. The role of Talin-1 in MCs/EOC adhesion was analyzed by genetic silencing. Talin-1 ectopic expression was validated as a rescue tool from MS-275-induced phenotype. The in vivo effect of MS-275-induced MC remodeling was validated in a mouse model of peritoneal EOC dissemination., [Results]: Treatment of MCs with non-cytotoxic concentrations of MS-275 caused a consistent reduction of EOC adhesion. Proteomic analysis revealed several pathways altered upon MC treatment with MS-275, including ECM deposition/remodeling, adhesion receptors and actin cytoskeleton regulators. HDAC1/2 inhibition hampered actin cytoskeleton polymerization by downregulating actin regulators including Talin-1, impairing β1 integrin activation, and leading to abnormal extracellular secretion and distribution of Fibronectin-1. Talin-1 ectopic expression rescued EOC adhesion to MS-275-treated MCs. In an experimental mouse model of metastatic EOC, MS-275 limited tumor invasion, Fibronectin-1 secretion and the sub-mesothelial accumulation of MC-derived carcinoma-associated fibroblasts., [Conclusion]: Our study unveils a direct impact of HDAC-1/2 in the regulation of MC/EOC adhesion and highlights the regulation of MC plasticity by epigenetic inhibition as a potential target for therapeutic intervention in EOC peritoneal metastasis., This research was funded by: AIRC (Associazione Italiana per la Ricerca sul Cancro) (IG26172) and Ateneo Sapienza Project 2020 (RG120172B8E53D03) to S.V; by FISR2019_00374 MeDyCa to AM; by FSE REACT-EU within the program PON “Research and Innovation” 2014–2020, Action IV.6 “Contratti di ricerca su tematiche Green” to CZ; by SEED PNR 2021 to C.B.; by AIRC IG26290, by Sapienza University of Rome (RG11916B6A9C42C7) to M. Tr and by Ministry for Health of Italy (Ricerca Corrente), by AIRC (IG21372 to LR), by PRIN 2022 PNRR (P2022XZKBM) financed by the European Union - NextGenerationEU», to RS. This work was also supported by grants (PID2019-110132RB-I00/AEI/https://doi.org/10.13039/501100011033 and PID2022-142796OB-I00/AEI/https://doi.org/10.13039/501100011033)) from the Spanish Ministry of Science and Innovation/Fondo Europeo de Desarrollo Regional (MICIN/FEDER) to ML-C and by a grant PID2021-123199OB-I00 from the Spanish Ministry of Science and Innovation/Fondo Europeo de Desarrollo Regional (MICIN/FEDER) to CC. MAdP is recipient/co-recipient of funding from the Spanish Ministry of Science and Innovation (MCIN) (refs. SAF2017–83130-R cofunded by “ERDF A way of making Europe”, PID2020-118658RB-I00, PDC2021–121572-100 cofunded by “European Union NextGeneration EU/PRTR”), Asociación Española Contra el Cáncer foundation (AECC; PROYE20089DELP); La Marató TV3 foundation (201936–30-31), Obra social La Caixa (AtheroConvergence, HR20–00075) and Comunidad Autónoma de Madrid/FEDER (Tec4Bio consortium, ref. S2018/NMT¬4443). MS-A is recipient of a Ramón y Cajal research contract from MCIN (RYC2020–029690-I) and research grant PID2021-128106NA-I00, both from Spanish MCIN. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation), and is a Severo Ochoa Center of Excellence (grant CEX2020–001041-S funded by MICIN/AEI/https://doi.org/10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020–001041-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Oral anticoagulants: A plausible new treatment for Alzheimer's disease?

  • Toribio-Fernández, Raquel
  • Cerón, Carlos
  • Tristão-Pereira, Catarina
  • Fernández-Nueda, Irene
  • Pérez-Castillo, Ana
  • Fernández-Ferro, José
  • Moro, María Ángeles
  • Ibáñez, Borja
  • Fuster, Valentín
  • Cortés-Canteli, Marta
Alzheimer's disease (AD) and cardiovascular disease (CVD) are strongly associated. Both are multifactorial disorders with long asymptomatic phases and similar risk factors. Indeed, CVD signatures such as cerebral microbleeds, micro-infarcts, atherosclerosis, cerebral amyloid angiopathy and a procoagulant state are highly associated with AD. However, AD and CVD co-development and the molecular mechanisms underlying such associations are not understood. Here, we review the evidence regarding the vascular component of AD and clinical studies using anticoagulants that specifically evaluated the development of AD and other dementias. Most studies reported a markedly decreased incidence of composite dementia in anticoagulated patients with atrial fibrillation, with the highest benefit for direct oral anticoagulants. However, sub-analyses by differential dementia diagnosis were scarce and inconclusive. We finally discuss whether anticoagulation could be a plausible preventive/therapeutic approach for AD and, if so, which would be the best drug and strategy to maximize clinical benefit and minimize potential risks., R. Toribio-Fernandez and M. Cortes-Canteli were supported by a Sara Borrell (CD20/00110) and Miguel Servet type II (CPII21/00007) research contracts from Instituto de Salud Carlos III co-funded by the European Union (Fondo Social Europeo Plus), respectively. C. Tristao-Pereira was supported by a La Caixa Foundation predoctoral fellowship (ID 100010434, LCF/BQ/DI19/11730052) and C. Ceron by a predoctoral fellowship from Fundación Española de Trombosis y Hemostasia (FETH-SETH). The CNIC is a Severo Ochoa Center of Excellence (CEX2020-001041-S)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001041-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Regulation of Myc transcription by an enhancer cluster dedicated to pluripotency and early embryonic expression

  • Li-Bao, Lin
  • Díaz-Díaz, Covadonga
  • Raiola, Morena
  • Sierra, Rocío
  • Temiño, Susana
  • Moya, Francisco J.
  • Rodríguez-Perales, Sandra
  • Santos, Elisa
  • Giovinazzo, Giovanna
  • Bleckwehl, Tore
  • Rada-Iglesias, Álvaro
MYC plays various roles in pluripotent stem cells, including the promotion of somatic cell reprogramming to pluripotency, the regulation of cell competition and the control of embryonic diapause. However, how Myc expression is regulated in this context remains unknown. The Myc gene lies within a ~ 3-megabase gene desert with multiple cis-regulatory elements. Here we use genomic rearrangements, transgenesis and targeted mutation to analyse Myc regulation in early mouse embryos and pluripotent stem cells. We identify a topologically-associated region that homes enhancers dedicated to Myc transcriptional regulation in stem cells of the pre-implantation and early post-implantation embryo. Within this region, we identify elements exclusively dedicated to Myc regulation in pluripotent cells, with distinct enhancers that sequentially activate during naive and formative pluripotency. Deletion of pluripotency-specific enhancers dampens embryonic stem cell competitive ability. These results identify a topologically defined enhancer cluster dedicated to early embryonic expression and uncover a modular mechanism for the regulation of Myc expression in different states of pluripotency., Grants PGC2018-096486-B-I00 and PID2022-140058NB-C31 from the Agencia Estatal de Investigación to M.T.; European Commission H2020 Program grant SC1-BHC-07-2019. Ref. 874764 “REANIMA” to M.T. Comunidad de Madrid grant P2022/BMD-7245 CARDIOBOOST-CM to M.T. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia, Innovación y Universidades (MICIU) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIU/AEI/10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001041-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Protein kinase D2 modulates hepatic insulin sensitivity in male mice

  • Rada, Patricia
  • Carceller-López, Elena
  • Hitos, Ana B.
  • Gómez-Santos, Beatriz
  • Fernández-Hernández, Constanza
  • Rey, Esther
  • Pose-Utrilla, Julia
  • García-Monzón, Carmelo
  • González-Rodríguez, Águeda
  • Sabio, Guadalupe
  • García, Antonia
  • Aspichueta, Patricia
  • Iglesias, Teresa
  • Valverde, Ángela M.
[Objectives]: Protein kinase D (PKD) family is emerging as relevant regulator of metabolic homeostasis. However, the precise role of PKD2 in modulating hepatic insulin signaling has not been fully elucidated and it is the aim of this study., [Methods]: PKD inhibition was analyzed for insulin signaling in mouse and human hepatocytes. PKD2 was overexpressed in Huh7 hepatocytes and mouse liver, and insulin responses were evaluated. Mice with hepatocyte-specific PKD2 depletion (PKD2ΔHep) and PKD2fl/fl mice were fed a chow (CHD) or high fat diet (HFD) and glucose homeostasis and lipid metabolism were investigated., [Results]: PKD2 silencing enhanced insulin signaling in hepatocytes, an effect also found in primary hepatocytes from PKD2ΔHep mice. Conversely, a constitutively active PKD2 mutant reduced insulin-stimulated AKT phosphorylation. A more in-depth analysis revealed reduced IRS1 serine phosphorylation under basal conditions and increased IRS1 tyrosine phosphorylation in PKD2ΔHep primary hepatocytes upon insulin stimulation and, importantly PKD co-immunoprecipitates with IRS1. In vivo constitutively active PKD2 overexpression resulted in a moderate impairment of glucose homeostasis and reduced insulin signaling in the liver. On the contrary, HFD-fed PKD2ΔHep male mice displayed improved glucose and pyruvate tolerance, as well as higher peripheral insulin tolerance and enhanced hepatic insulin signaling compared to control PKD2fl/fl mice. Despite of a remodeling of hepatic lipid metabolism in HFD-fed PKD2ΔHep mice, similar steatosis grade was found in both genotypes., [Conclusions]: Results herein have unveiled an unknown role of PKD2 in the control of insulin signaling in the liver at the level of IRS1 and point PKD2 as a therapeutic target for hepatic insulin resistance., This work was funded by grants PID2023-150994OB-I00 funded by MICIU/AEI/10.13039/501100011033 and by “ERDF/EU” to PR; PID-2021-122766OB-100 funded by MICIU/AEI/10.13039/501100011033 and by “ERDF/EU” to AMV; PID2020-115218RB-I00 funded by MICIU/AEI/10.13039/501100011033 and by “ERDF A way of making Europe” to TI; PID2021-124425OB-I00 funded by MICIU/AEI/10.13039/501100011033 and by “ERDF/EU” to PA; PDC2021-121147-I00 funded by MICIU/AEI/10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR” to GS. We also acknowledge grants PI20/00837 to CG-M, PMP21/00057 to GS and PA, and PI22/01968 to ÁG-R funded by Instituto de Salud Carlos III/FEDER (Spain), and IT1476-22 funded by Basque Government, Department of Education (Spain) to PA, grants P2022/BMD-7227 funded by Comunidad de Madrid (Spain) to AMV and AG and funding from CIBERDEM (ISCIII, Spain) to AMV and CIBERNED (ISCIII, Spain) to TI, including PR and JPU research contracts, respectively. CNIC is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033). EC-L is funded by Comunidad de Madrid and Fondo Social Europeo (ref. PEJ-2020-AI/BMD-18301)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001041-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Shaping current European mitochondrial haplogroup frequency in response to infection: the case of SARS-CoV-2 severity

  • Cabrera-Alarcon, José Luis
  • Cruz, Raquel
  • Rosa-Moreno, Marina
  • Latorre-Pellicer, Ana
  • Diz de Almeida, Silvia
  • Scourge Cohort Group
  • Riancho, José A.
  • Rojas-Martinez, Augusto
  • Flores, Carlos
  • Lapunzina, Pablo
  • Sánchez-Cabo, Fátima
  • Carracedo, Ángel
  • Enriquez, José Antonio
Scourge Cohort Group: Javier Abellán, René Acosta-Isaac, Jose María Aguado, Carlos Aguilar, Sergio Aguilera-Albesa, Abdolah Ahmadi Sabbagh, Jorge Alba, Sergiu Albu, Karla A. M. Alcalá-Gallardo, Julia Alcoba-Florez, Sergio Alcolea Batres, Holmes Rafael Algarin-Lara, Virginia Almadana, Kelliane A. Medeiros, Julia Almeida, Berta Almoguera, María R. Alonso, Nuria Álvarez, Rodolfo Álvarez-Sala Walther, Yady Álvarez-Benítez, Felipe Álvarez-Navia, Katiusse A. dos Santos, Álvaro Andreu-Bernabeu, Maria Rosa Antonijoan, Eleno Martínez-Aquino, Eunate Arana-Arri, Carlos Aranda, Celso Arango, Carolina Araque, Nathalia K. Araujo, Ana C. Arcanjo, Ana Arnaiz, Francisco Arnalich Fernández, María J. Arranz, José Ramón Arribas López, Maria-Jesús Artiga, Yubelly Avello-Malaver, Carmen Ayuso, Belén Ballina Martín, Raúl C. Baptista-Rosas, Ana María Baldion, Andrea Barranco-Díaz, María Barreda-Sánchez, Viviana Barrera-Penagos, Moncef Belhassen-Garcia, David Bernal-Bello, Enrique Bernal, Joao F. Bezerra, Marcos A. C. Bezerra, Natalia Blanca-López, Rafael Blancas, Lucía Boix-Palop, Alberto Borobia, Elsa Bravo, María Brion, Óscar Brochado-Kith, Ramón Brugada, Matilde Bustos, Alfonso Cabello, Alejandro Cáceres, Juan J. Cáceres-Agra, Esther Calbo, Enrique J. Calderón, Shirley Camacho, Francisco C. Ceballos, Yolanda Cañadas, Cristina Carbonell, Servando Cardona-Huerta, María Sánchez-Carpintero Abad, Carlos Carpio-Segura, José Antonio Carrillo-Avila, Marcela C. Campos, Carlos Casasnovas, Luis Castaño, Carlos F. Castaño, Jose E. Castelao, Aranzazu Castellano Candalija, María A. Castillo, Walter G. Chaves-Santiago, Sylena Chiquillo-Gómez, Marco A. Cid-López, Óscar Cienfuegos-Jiménez, Rosa Conde-Vicente, Gabriela C. R. Cunha, M. Lourdes Cordero-Lorenzana, Dolores Corella, Almudena Corrales, Jose L. Cortés-Sánchez, Marta Corton, Karla S. C. Souza, Fabiola T. C. Silva, Raquel Cruz, Luisa Cuesta, Nathali A. C. Tavares, Maria C. C. Carvalho, David Dalmau, Raquel C. S. Dantas-Komatsu, M. Teresa Darnaude, Raimundo de Andrés, Carmen de Juan, Juan J. de la Cruz Troca, Carmen de la Horra, Ana B. de la Hoz, Alba De Martino-Rodríguez, Marina S. Cruz, Julianna Lys de Sousa Alves Neri, Victor del Campo-Pérez, Juan Delgado-Cuesta, Aranzazu Diaz de Bustamante, Anderson Díaz-Pérez, Beatriz Dietl, Silvia Diz-de Almeida, Manoella do Monte Alves, Elena Domínguez-Garrido, Lidia S. Rosa, Andre D. Luchessi, Jose Echave-Sustaeta, Rocío Eiros, César O. Enciso-Olivera, Gabriela Escudero, Pedro Pablo España, Gladys Estigarribia Sanabria, María Carmen Fariñas, Ramón Fernández, Lidia Fernández-Caballero, Ana Fernández-Cruz, Silvia Fernández-Ferrero, Yolanda Fernández Martínez, María J. Fernandez-Nestosa, Uxía Fernández-Robelo, Amanda Fernández-Rodríguez, Marta Fernández-Sampedro, Ruth Fernández, Tania Fernández-Villa, Carmen Fernández-Capitán, Antonio Augusto F. Carioca, Patricia Flores-Pérez, Lácides Fuenmayor-Hernández, Marta Fuertes-Núñez, Victoria Fumadó, Ignacio Gadea, Lidia Gagliardi, Manuela Gago-Domínguez, Natalia Gallego, Cristina Galoppo, Ana García-Soidán, Carlos García-Cerrada, Aitor García-de-Vicuña, Josefina Garcia-García, Irene García-García, Carmen García-Ibarbia, Andrés C. García-Montero, Leticia García, Mercedes García, María Carmen García Torrejón, Inés García, Elisa García-Vázquez, Emiliano Garza-Frias, Angela Gentile, Belén Gil-Fournier, Jéssica N. G. de Araújo, Mario Gómez-Duque, Javier Gómez-Arrue, Luis Gómez Carrera, María Gómez García, Ángela Gómez Sacristán, Juan R. González, Anna González-Neira, Beatriz González Álvarez, Fernán González Bernaldo de Quirós, Rafaela González-Montelongo, Javier González-Peñas, Manuel Gonzalez-Sagrado, Hugo Gonzalo-Benito, Oscar Gorgojo-Galindo, Miguel Górgolas, Florencia Guaragna, Jessica G. Chaux, Encarna Guillén-Navarro, Beatriz Guillén-Guío, Pablo Guisado-Vasco, Luz D. Gutiérrez-Castañeda, Juan F. Gutiérrez-Bautista, Sara Heili-Frades, Rafael H. Jacomo, Estefania Hernández, Cristina Hernández-Moro, Luis D. Hernández-Ortega, Guillermo Hernández-Pérez, Rebeca Hernández-Vaquero, Belén Herráez, M. Teresa Herranz, María Herrera, María José Herrero, Antonio Herrero-González, Juan P. Horcajada, Natale Imaz-Ayo, Maider Intxausti-Urrutibeaskoa, Antonio Íñigo-Campos, María Íñiguez, Rubén Jara, Ángel Jiménez, Pilar Jiménez, María A. Jiménez-Sousa, Iolanda Jordan, Ignacio Jiménez-Alfaro, Rocío Laguna-Goya, Daniel Laorden, María Lasa-Lázaro, María Claudia Lattig, Ailen Lauriente, Anabel Liger Borja, Lucía Llanos, Amparo López-Bernús, Miguel López de Heredia, Esther Lopez-Garcia, Eduardo López-Granados, Rosario Lopez-Rodriguez, Miguel A. López-Ruz, Leonardo Lorente, José M. Lorenzo-Salazar, José E. Lozano, María Lozano-Espinosa, Ignacio Mahillo, Esther Mancebo, Carmen Mar, Cristina Marcelo Calvo, Alba Marcos-Delgado, Miguel Marcos, Alicia Marín-Candón, Pablo Mariscal-Aguilar, Laura Martin-Pedraza, Marta Martin-Fernandez, Caridad Martín-López, José-Ángel Martín-Oterino, María Dolores Martín, Vicente Martín, María M. Martín, María Martín-Vicente, Amalia Martinez, Óscar Martínez-González, Ricardo Martínez, Pedro Martinez-Paz, Covadonga M. Díaz-Caneja, Óscar Martínez-Nieto, Iciar Martínez-López, Michel F. Martínez-Reséndez, Silvia Martínez, Juan José Martínez, Ángel Martínez-Pérez, Andrea Martínez-Ramas, Violeta Martínez-Robles, Laura Marzal, Juliana F. Mazzeu, Francisco J. Medrano, Xose M. Meijome, Natalia Mejuto-Montero, Ingrid Mendes, Alice L. Duarte, Ana Méndez-Echevarría, Humberto Mendoza Charris, Eleuterio Merayo Macías, Fátima Mercadillo, Arieh R. Mercado-Sesma, Pablo Mínguez, Elena Molina-Roldán, Antonio J. J. Molina, Juan José Montoya, Susana M. T. Pinho, Patricia Moreira-Escriche, Xenia Morelos-Arnedo, Rocío Moreno, Víctor Moreno Cuerda, Antonio Moreno-Docón, Junior Moreno-Escalante, Alberto Moreno Fernández, Patricia Muñoz García, Pablo Neira, Julián Nevado, Israel Nieto-Gañán, Vivian N. Silbiger, Rocío Nuñez-Torres, Antònia Obrador-Hevia, J. Gonzalo Ocejo-Vinyals, Virginia Olivar, Silviene F. Oliveira, Lorena Ondo, Alberto Orfao, Eva Ortega-Paino, Luis Ortega, Rocío Ortiz-López, Fernando Ortiz-Flores, José A. Oteo, Manuel Pacheco, Fredy Javier Pacheco-Miranda, Irene Padilla-Conejo, Sonia Panadero-Fajardo, Mara Parellada, Roberto Pariente-Rodríguez, Vicente Friaza, Estela Paz-Artal, Germán Peces-Barba, Miguel S. Pedromingo Kus, Celia Perales, Ney P. C. Santos, Genilson P. Guegel, María Jazmín Pérez, Alexandra Pérez, Patricia Pérez-Matute, César Pérez, Gustavo Pérez-de-Nanclares, Felipe Pérez-García, Patricia Pérez, Luis A. Pérez-Jurado, M. Elena Pérez-Tomás, Teresa Perucho, Lisbeth A. Pichardo, Adriana P. Ribeiro, Mel·lina Pinsach-Abuin, Luz Adriana Pinzón, Jeane F. P. Medeiros, Guillermo Pita, Francesc Pla-Juncà, Laura Planas-Serra, Ericka N. Pompa-Mera, Gloria L. Porras-Hurtado, Aurora Pujol, María Eugenia Quevedo-Chávez, Maria Angeles Quijada, Inés Quintela, Soraya Ramiro-León, Pedro Rascado Sedes, Joana F. R. Nunes, Delia Recalde, Emma Recio-Fernández, Salvador Resino, Renata R. Sousa, Carlos S. Rivadeneira-Chamorro, Diana Roa-Agudelo, Montserrat Robelo Pardo, Marianne R. Fernandes, María A. Rodríguez-Hernández, Agustí Rodriguez-Palmero, Emilio Rodríguez-Ruiz, Marilyn Johanna Rodriguez, Fernando Rodríguez-Artalejo, Marena Rodríguez-Ferrer, Carlos Rodríguez-Gallego, José A. Rodríguez-García, Belén Rodríguez Maya, Antonio Rodriguez-Nicolas, German Ezequiel Rodríguez-Novoa, Paula A. Rodriguez-Urrego, Federico Rojo, Andrea Romero-Coronado, Rubén Morilla, Filomeno Rondón-García, Antonio Rosales-Castillo, Cladelis Rubio, María Rubio Olivera, Francisco Ruiz-Cabello, Eva Ruiz-Casares, Juan J. Ruiz-Cubillan, Javier Ruiz-Hornillos, Montserrat Ruiz, Pablo Ryan, Hector D. Salamanca, Lorena Salazar-García, Giorgina Gabriela Salgueiro-Origlia, Anna Sangil, Olga Sánchez-Pernaute, Pedro-Luis Sánchez, Antonio J. Sánchez López, Clara Sánchez-Pablo, María Concepción Sánchez-Prados, Javier Sánchez-Real, Jorge Sánchez-Redondo, Cristina Sancho-Sainz, Esther Sande, Arnoldo Santos, Agatha Schlüter, Sonia Segovia, Alex Serra-Llovich, Fernando Sevil-Puras, Marta Sevilla-Porras, Miguel A. Sicolo, Cristina Silván-Fuentes, Vitor M. S. Moraes, Vanessa S. Souza, Jordi Solé-Violán, José Manuel Soria, Jose V. Sorlí, Nayara S. Silva, Juan Carlos Souto, John J. Sprockel, José Javier Suárez-Rama, David A. Suárez-Zamora, Xiana Taboada-Fraga, Eduardo Tamayo, Alvaro Tamayo-Velasco, Juan Carlos Taracido-Fernández, Romero H. T. Vasconcelos, Carlos Tellería, Thássia M. T. Carratto, Jair Antonio Tenorio-Castaño, Alejandro Teper, Izabel M. T. Araujo, Juan Torres-Macho, Lilian Torres-Tobar, Ronald P. Torres-Gutiérrez, Jesús Troya, Miguel Urioste, Juan Valencia-Ramos, Agustín Valido, Juan Pablo Vargas-Gallo, Belén Varón, Tomas Vega, Santiago Velasco-Quirce, Valentina Vélez-Santamaría, Virginia Víctor, Julia Vidán-Estévez, Gabriela V. Silva, Miriam Vieitez-Santiago, Carlos Vilches, Lavinia Villalobos, Felipe Villar, Judit Villar-Garcia, Cristina Villaverde, Pablo Villoslada-Blanco, Ana Virseda-Berdices, Tatiana X. Costa, Zuleima Yáñez, Antonio Zapatero-Gaviria, Ruth Zarate, Sandra Zazo, Carlos Flores, José A. Riancho, Augusto Rojas-Martinez, Pablo Lapunzina & Ángel Carracedo, The frequency of mitochondrial DNA haplogroups (mtDNA-HG) in humans is known to be shaped by migration and repopulation. Mounting evidence indicates that mtDNA-HG are not phenotypically neutral, and selection may contribute to its distribution. Haplogroup H, the most abundant in Europe, improved survival in sepsis. Here we developed a random forest trained model for mitochondrial haplogroup calling using data procured from GWAS arrays. Our results reveal that in the context of the SARS-CoV-2 pandemic, HV branch were found to represent protective factors against the development of critical SARS-CoV-2 in an analysis of 14,349 patients. These results highlight the role of mtDNA in the response to infectious diseases and support the proposal that its expansion and population proportion has been influenced by selection through successive pandemics., The authors thank M. M. Muñoz-Hernandez, R. Martínez de Mena and E.R. Martínez Jiménez, for technical assistance. Scheme figures were made with BioRender. We particularly acknowledge all the patients, Banco Nacional de ADN, Biobanco del Sistema de Salud de Aragón, Biobanc Fundació Institut d'Investigació Sanitària Illes Balears, Biobanco del Complexo Hospitalario Universitario de Santiago, Biobanco Vasco, for their collaboration and providing materials. JAE laboratory is supported by: RTI2018-099357-B-I00 and PID2021-1279880B-and TED2021-131611B-I00 funded by MCIN/AEI/10.13039/501100011033 and the, and CIBERFES (CB16/10/00282), Human Frontier Science Program (grant RGP0016/2018), and Leducq Transatlantic Networks (17CVD04). MR-M is supported by a FPI/PRE2021-097721 fellowship. JAE and FSC are supported by TED2021-131611B-I00 funded by MCIN/AEI/10.13039/501100011033 and the European Union “NextGenerationEU”/Plan de Recuperación Transformación y Resiliencia -PRTR. FSC received funding [grant no. PID2022-141527OB-I00] by the MCIN/AEI/10.13039/501100011033/ and by FEDER Una manera de hacer Europa. This work was supported by Fundación Amancio Ortega Gaona, Banco de Santander S.A. and Instituto de Salud Carlos III (COV20/00622) and the European Regional Development Fund. Genotyping service was carried out at CEGEN-PRB3-ISCIII, supported by grant PT17/0019, of the PE I+D+i 2013-2016, funded by ISCIII and ERDF. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation) and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Absence of MCJ/DnaJC15 promotes brown adipose tissue thermogenesis

  • Cicuéndez, Beatriz
  • Mora, Alfonso
  • López, Juan Antonio
  • Curtabbi, Andrea
  • Pérez-García, Javier
  • Porteiro, Begoña
  • Jimenez-Blasco, Daniel
  • Latorre-Muro, Pedro
  • Vo, Paula
  • Jerome, Madison
  • Gómez-Santos, Beatriz
  • Romero-Becerra, Rafael
  • Leiva, Magdalena
  • Rodríguez, Elena
  • León, Marta
  • Leiva-Vega, Luis
  • Gómez-Lado, Noemi
  • Torres, Jorge L.
  • Hernández-Cosido, Lourdes
  • Aguiar, Pablo
  • Marcos, Miguel
  • Jastroch, Martin
  • Daiber, Andreas
  • Aspichueta, Patricia
  • Bolaños, Juan P.
  • Spinelli, Jessica B.
  • Puigserver, Pere
  • Enriquez, José Antonio
  • Vázquez, Jesús
  • Folgueira, Cintia
  • Sabio, Guadalupe
Obesity poses a global health challenge, demanding a deeper understanding of adipose tissue (AT) and its mitochondria. This study describes the role of the mitochondrial protein Methylation-controlled J protein (MCJ/DnaJC15) in orchestrating brown adipose tissue (BAT) thermogenesis. Here we show how MCJ expression decreases during obesity, as evident in human and mouse adipose tissue samples. MCJKO mice, even without UCP1, a fundamental thermogenic protein, exhibit elevated BAT thermogenesis. Electron microscopy unveils changes in mitochondrial morphology resembling BAT activation. Proteomic analysis confirms these findings and suggests involvement of the eIF2α mediated stress response. The pivotal role of eIF2α is scrutinized by in vivo CRISPR deletion of eIF2α in MCJKO mice, abrogating thermogenesis. These findings uncover the importance of MCJ as a regulator of BAT thermogenesis, presenting it as a promising target for obesity therapy., We thank Electron Microscopy Facility (Centro Nacional de Biotecnología, CSIC) for preparing samples (Epon embedding), obtaining the ultrathin sections and TEM visualization. The project that gave rise to these results received the support of a fellowship from” la Caixa” Foundation (ID 100010434). The fellowship code is LCF/BQ/DR21/11880010 to B.C. C.F was funded with Sara Borrell (CD19/ 00078), NNF23SA0083952-EASO/Novo Nordisk New Investigator Award in Basic Sciences 2023, EFSD/Lilly Young Investigator Award 2022, Society for Endocrinology/Early Career Grant 2022, FSEEN/ Jóvenes endocrinólogos 2022, EFSD/Novo Nordisk Rising Star 2024, IBSA Foundation Fellowship Endocrinology 2023. This work has been supported by the following projects: PMP21/00057 funded by the Instituto de Salud Carlos III (ISCIII) - European Union (FEDER/FSE) “Una manera de hacer Europa”/ “El FSE invierte en tu futuro”/ Next Generation EU and cofunded by the European Union / Plan de Recuperación, Transformación y Resiliencia (PRTR); PID2022-138525OB-I00 de la Agencia Estatal de Investigación 10.13039/501100011033, financiado por MICIU/AEI/10.13039/501100011033 fondos FEDER and EU, PDC2021-121147-I00 and PID2019-104399RB-I00 funded by MCIN/AEI/10.13039/501100011033 and the European Union “NextGenerationEU”/Plan de Recuperación Transformación y Resiliencia -PRTR; Grant RED2022-134397-T funded by MCIN/AEI/10.13039/501100011033 and, as appropriate, by “ERDF A way of making Europe”, by the “European Union” or by the “European Union NextGenerationEU/PRTR”; Fundación Jesús Serra; EFSD/Lilly Dr Sabio; 2017 Leonardo Grant BBVA Foundation (Investigadores-BBVA-2017); Comunidad de Madrid IMMUNOTHERCAN-CM S2010/BMD-2326 and B2017/BMD-373; Fundación AECC PROYE19047SABI. PreMed-Exp: PMP21/00057, PMP21/00113 Infraestructura de Medicina de Precisión asociada a la Ciencia y Tecnología IMPACT-2021, Instituto de Salud Carlos III (GS, JLT). The project leading to these results has received funding from the” la Caixa” Foundation under the project code “HR24-00581” (G.S). G.S is a Miembro Numerario of the RACVE. J.P-G was supported by the fellowship from” la Caixa” Foundation (ID 100010434), the fellowship code is LCF/BQ/DR24/12080018. A.C was supported by the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement n. 713,673 and by Becas de doctorado INPhINIT “la Caixa” 2018. PLM acknowledges NIH NIDDK grant K99DK133502. M.M is supported by Instituto de Salud Carlos III (ISCIII) and the European Union project PI20/00743. P.A is supported by MCIU/AEI/FEDER, UE (PID2021-124425OB-I00) and Basque Government, Department of Education (IT1476-22) and PMP21/00080 de Medicina de Precisión asociada a la Ciencia y Tecnología IMPACT-2021, Instituto de Salud Carlos III. J.P.B is funded by MICIU/AEI (PID2022-138813OB-I00), la Caixa Foundation (grant agreement LCF/PR/HR23/52430016), Instituto de Salud Carlos III (CB16/10/00282) and the European Union’s Horizon Europe research and innovation program under the MSCA Doctoral Networks 2021 (101072759; FuEl ThEbRaiN In healtThY aging and age-related diseases, ETERNITY), AEI grants PID2019-105699RB-I00, PID2022-138813OB-I00 and PDC2021-121013-I00; HORIZON-MSCA-2021-DN-01grant 101072759; and La Caixa Research Health grant HR23-00793. PP acknowledges NIH grant R01DK136640. JAE was supported by competitive grants: PID2021-127988OB-I00 funded by MCIN/AEI/10.13039/501100011033/ FEDER, UE; Human Frontier Science Program (grant RGP0016/2018), Leducq Transatlantic Networks (17CVD04) and CIBERFES [CB16/10/00282], Centro de Investigación Biomédica. Instituto de Salud Carlos III.The CNIO and CNIC are supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation) and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A New GlyT2 Variant Associated with Hyperekplexia

  • Sarmiento-Jiménez, Jorge
  • Felipe, Raquel
  • Núñez, Enrique
  • Ferrando-Muñoz, Alejandro
  • Benito-Muñoz, Cristina
  • Gago, Federico
  • Vázquez, Jesús
  • Camafeita, Emilio
  • Clement, Emma
  • Wilson, Brian
  • López-Corcuera, Beatriz
This article belongs to the Special Issue Genetic and Genomic Diagnostics for Rare Diseases., [Data Availability Statement] The datasets generated and/or analyzed during the current study are not publicly available due to individual privacy, but some data are available from the corresponding author on reasonable request. Proteomic data are available via ProteomeXchange with the identifier PXD061845., Hyperekplexia (OMIM 149400), a sensorimotor syndrome of perinatal clinical relevance, causes newborns to display an energic startle reflex in response to certain trivial stimuli. This condition can be lethal due to apnea episodes. The disease is caused by a blockade of glycinergic neurotransmission. Glycinergic interneurons preserve their identity by the activity of the surface glycine transporter GlyT2, which supplies glycine to presynaptic terminals to maintain glycine content in synaptic vesicles. Loss-of-function mutations in the GlyT2 gene (SLC6A5) cause a presynaptic form of human hyperekplexia. Here, we describe a new GlyT2 variant found in an infantile patient diagnosed with hyperekplexia. A missense mutation in the open reading frame of the GlyT2 gene inherited in homozygosity caused the substitution G449E in a residue highly conserved across the phylogenetic scale. The sequences of the glycine receptor genes GLRA1 and GLRB did not show abnormalities. We expressed the recombinant GlyT2 variant in heterologous cells and analyzed its pathogenic mechanism. The transporter was totally inactive, behaving as a bona fide loss-of-function mutant. Furthermore, the mutation promoted the abnormal insertion of the protein into the membrane, leading to its large incorporation into lipid rafts. However, there was no apparent alteration of wild-type trafficking upon mutant coexpression, as the mutant was prematurely degraded from the endoplasmic reticulum. Rescue with chemical chaperones was not possible for this mutant. Proteomics demonstrated that the expression of the mutant induced the unfolded protein response and interfered with raft-dependent processes. Therefore, the new variant causes a loss of function regarding GlyT2 activity but a gain of function as a cell proteostasis disturber., This research was funded by the Ministerio de Ciencia e Innovación (MCIN) MCIN/AEI/10.13039/501100011033, grant numbers PID2020-119399RB-I00 and PID2023-150608OB-I00 to B.L.-C.; the Fundación Ramón Areces, grant number CIVP20A6612 to B.L.-C.; and an institutional grant from the Fundación Ramón Areces to the CBM Severo Ochoa. The work at the CNIC was supported by grant EQC2021-007053-P funded by MCIN/AEI/10.13039/501100011033 and by NextGenerationEU/PRTR; grant PID2021-122348NB-I00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”; grant PLEC2022-009298 funded by MCIN/AEI/10.13039/501100011033 and by “European Union NextGenerationEU/PRTR”; grant PLEC2022-009235 funded by MCIN/AEI/10.13039/501100011033 and by “European Union NextGenerationEU/PRTR”; grant S2022/BMD-7333-CM (INMUNOVAR-CM) funded by Comunidad de Madrid; and “la Caixa” Foundation under the project code LCF/PR/HR22/52420019 to J.V. The CBMSO is a Severo Ochoa Center of Excellence (CEX2021-001154-S). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033). Work at the University of Alcalá was supported by the MCIN grant PID2022-136307OB-C22/AEI/10.13039/501100011033., With funding form the Spanish government through the "Severa Ochoa Centre of Excellence" accreditation (CEX2021-001154-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Role of Extracellular Vesicles in Chronic Post-Embolic Pulmonary Hypertension: Data from an Experimental Animal Model and Patients

  • Mendoza-Zambrano, Elva María
  • Sánchez-López, Verónica
  • Gómez-Rodríguez, Belén
  • García-Lunar, Inés
  • Pereda-Arnau, Daniel
  • Jara Palomares, Luis
  • Elías-Hernández, Teresa
  • García-Álvarez, Ana
  • Otero-Candelera, Remedios
This article belongs to the Special Issue Molecular and Translational Research in Cardiovascular Disease., [Background:] The pathogenesis of chronic thromboembolic pulmonary hypertension (CTEPH) involves a multifaceted interplay of factors, including incomplete thrombus resolution, endothelial dysfunction, and vascular remodeling. Recent studies have highlighted the role of extracellular vesicles (EVs) in vascular diseases, suggesting their potential involvement in CTEPH progression. This study aims to investigate the role of EVs from various cellular sources in the development of CTEPH. Methods, [Methods:] An experimental study was conducted using 11 male three-month-old Large-White pigs. The EVs of endothelial origin (EEVs; CD146+), leukocyte-derived EVs (LEVs; CD45+, CD44+), and consistent with mesenchymal-origin EVs (CD90+, CD105+) were quantified. Measurements were taken at baseline, after the first embolization, and prior to each subsequent weekly embolization. Embolizations were repeated until chronic pulmonary hypertension (PH) was generated. Based on these findings, a clinical case-control study was performed involving nine patients previously diagnosed with CTEPH and 18 patients with pulmonary embolism who did not develop CTEPH after two years of follow-up., [Results:] The experimental study, consistent with the mesenchymal-origin EVs, exhibited a progressive decrease below baseline levels; LEVs decreased after PH was established, while EEVs remained elevated throughout the study. Subsequently, in the clinical case-control study, CD45+ LEVs emerged as a significant association of CTEPH, with an odds ratio (OR) of 21.25 (95% CI: 1.91–236.00; p = 0.013)., [Conclusions:] Inflammation involving LEVs and EEVs plays a crucial role in sustaining the vascular alterations leading to pulmonary vasculature remodeling in CTEPH., This work was supported by the Carlos III Health Institute [PI11/02308]; Spanish Society of Pulmonology and Thoracic Surgery, SEPAR [124/2011]; Ministry of Economy, Innovation, Science and Employment of the Junta de Andalucía [CVI-6654/2010]; CNIC is supported by the Carlos III Health Institute (ISCIII), the Ministerio de Ciencia e Innovación (MICIU) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033). I.G.-L. is supported by project "PI24/00260", funded by Carlos III Health Institute (ISCIII) and co-funded by the European Union., With funding form the Spanish government through the "Severa Ochoa Centre of Excellence" accreditation (CEX2020-001041-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Survey for Human Tissue-Level Determinants of CAV1 Regulation and Function

  • Jiménez-Jiménez, Victor
  • Sánchez Cabo, Fátima
  • Schwartz, Martin A.
  • Sánchez-Álvarez, Miguel
  • Pozo, Miguel Angel
CAV1 is a protein-coding gene linked to several disorders, including cancer, lipodystrophy, and cardiovascular diseases. While its ability to respond to various mechanical and metabolic stimuli has been documented, a comprehensive understanding of its physiological regulation in humans is lacking. We leveraged the comprehensiveness of human post-mortem tissue data from the Genotype-Tissue Expression (GTEx) consortium, systematically exploring the sources of variability in CAV1 transcriptional levels using extensive bulk and single-nuclei RNA-seq datasets. This human-centric approach, avoiding inter-species comparisons, constitutes a unique resource to explore CAV1 regulation within the complexity of human tissues. Notably, cell type proportion was identified as a major determinant of CAV1 transcription levels across tissues. Donor physiological conditions, including disease states and end-of-life circumstances, also exhibited a tissue-specific influence. Among primary upstream regulators associated with CAV1, chromatin modifiers stood out, especially SMARCA2, which showed a positive correlation across tissues, and PRC2 complexes, which exhibited tissue-specific correlation. Upstream regulatory networks determining CAV1 levels are also enriched for annotations such as mechanobiology (e.g., TEAD4), immunity (e.g., RELA and STAT3), and metabolism (e.g., MYC and NRF1). A remarkable observation was a strong correlation between CAV1 and the relative infiltration of immune cells across tissues, supporting a potential role for CAV1 as a marker and driver of tissue immune infiltration., M.Á.d.P. is a recipient of grants from the Spanish Ministry of Science and Innovation (MCIN) (refs. SAF2017–83130-R cofunded by “ERDF A way of making Europe”, PID2020-118658RB-I00, PDC2021–121572-100 cofunded by “European Union NextGeneration EU/PRTR”), Asociación Española Contra el Cáncer foundation (AECC; PROYE20089DELP); La Marató TV3 foundation (201936–30-31), Fundación Obra social La Caixa (AtheroConvergence, HR20–00075; of which he is the coordinator) and Comunidad Autónoma de Madrid/FEDER (Tec4Bio consortium, ref. S2018/NMT¬4443). M.S.-Á. is a recipient of a Ramón y Cajal research contract from MCIN (RYC2020–029690-I) and research grants PID2021-128106NA-I00 and CNS2023-144831, all from Spanish MCIN. M.Á.d.P. received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement 641639 in the context of the BIOPOL ITN consortia, of which V.J.-J. was an ESR. V.J.-J. was also supported by the La Caixa and Deutscher Akademischer Austauschdienst scholarship. M.A.S. is Robert W. Berliner Professor of Medicine and co-recipient of the AtheroConvergence grant from Fundación Obra social La Caixa (HR20–00075). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN), and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033). The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001041-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

PERK-dependent reciprocal crosstalk between ER and non-centrosomal microtubules coordinates ER architecture and cell shape

  • Sánchez-Álvarez, Miguel
  • Nicolás Lolo, Fidel
  • Sailem, Heba
  • Fulgoni, Giulio
  • Pascual, Patricia
  • Agüera, Lucía
  • Catalá-Montoro, Mauro
  • Arias-García, Mar
  • López, Juan Antonio
  • Vázquez, Jesús
  • Pozo, Miguel Angel
  • Bakal, Chris
The architecture of the endoplasmic reticulum (ER) is a key determinant of its function. Its dynamics are linked to those of the cytoskeleton, but our understanding of how this coordination occurs and what its functional relevance is, limited. Here, we report that the unfolded protein response (UPRER) transducer EIF2AK3/PERK (eukaryotic translation initiation factor 2-alpha kinase 3/protein kinase R-like endoplasmic reticulum kinase) is essential for acute-stress-induced peripheral redistribution and remodeling of the ER through eukaryotic initiation factor 2 alpha (eIF2α) phosphorylation and translation initiation shutdown. PERK-mediated eIF2α phosphorylation can be bypassed by blocking polysome assembly, depleting microtubule (MT)-anchoring ER proteins such as p180/RRBP1 (ribosome-binding protein 1), or disrupting the MT cytoskeleton. Specific disruption of non-centrosomal MTs, but not centrosome depletion, rescues ER redistribution in PERK-deficient cells. Conversely, PERK deficiency stabilizes non-centrosomal MTs against proteasomal degradation, promoting polarized protrusiveness in epithelial cells and neuroblasts. Thus, PERK coordinates ER architecture and homeostasis with cell morphogenesis by coupling ER remodeling and non-centrosomal MT stability and dynamics., Light microscopy and dynamic imaging/ICTS-ReDib at CNIC is supported by MCIN/AEI/10.13039/501100011033 and FEDER “Una manera de hacer Europa” (#ICTS-2018-04-CNIC-16; Madrid, Spain). Amine Sadok and Faraz Mardakheh (former researchers at ICR, London, UK) provided expert advice and assistance with collagen migration experiments. C.B. and H.S. have been beneficiaries of the Wellcome Trust Career Development Fellowship program. Funding support at the C.B. lab was received from the Cancer Research UK (CRUK) Programme Foundation Award (C37275/A20146) and the Stand Up to Cancer campaign. M.S.-A. was a fellow of the COFUND-IPP program (CNIC); is a recipient of grants from the Spanish Ministerio de Ciencia e Innovación (MICINN; RYC2020-029690-I and PID2021-128106NA-I00) and the Scientific Foundation, Spanish Association Against Cancer (LAB AECC 2024 grant LABAE246690SANC); and is supported by consolidation grant CNS2023-144831, sponsored by Ministerio de Ciencia, Innovación y Universidades (MICIU)/AEI/10.13039/501100011033 and European Union NextGenerationEU/PRTR. The M.A.d.P. lab is sponsored by Spanish Ministerio de Ciencia e Innovación (MCNU; PID2020-118658RB-I00, SAF2017-83130-R, and BFU2016-81912-REDC); the Comunidad Autónoma de Madrid/FEDER, Spain (ref. S2018/NMT4443; Actividades de I+D entre Grupos de Investigación en Tecnologías); Obra Social La Caixa (AtheroConvergence-HR20-00075); and the Fundació la Marató de TV3 (385/C/2019). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia, Innovación y Universidades (MICIU), and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIU/AEI/10.13039/501100011033). The M.S-A. laboratory is a member of the RER-CSIC rare disease research network., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001041-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A signal-responsive cooperative transcription factor network determines alveolar macrophage identity

  • Mínguez-Martínez, Jorge
  • Porcuna, Jesús
  • Casablanca, Laura
  • Gómez, Manuel J
  • Aghelpasand, Hooman
  • Höjer, Pontus
  • García-Fojeda, Belén
  • Núñez, Vanessa
  • Torroja, Carlos
  • Mühleder, Severin
  • Gustafsson, Charlotte
  • Fischer, Thierry
  • Benedito, Rui
  • Casals, Cristina
  • Månsson, Robert
  • Sánchez-Cabo, Fátima
  • Ricote, M. Mercedes
Tissue-resident macrophages receive signals from their microenvironment that coordinate the activity of transcription factors (TFs) to establish distinct transcriptional profiles and identities. However, the molecular mechanisms whereby interactions with other cells of the niche imprint a distinct macrophage identity remain poorly understood. Here, we report that retinoid X receptors (RXRs) determine the differentiation and identity of alveolar macrophages (AM) by regulating chromatin accessibility and transcriptional activity of AM-core and function genes, enabling PPARγ-dependent programs. AM differentiation and maintenance in vivo require RXR upregulation in response to tissue-derived δ-like canonical Notch ligand 4 (DLL4), GM-CSF, and TGF β (TGFβ). Interplay among these signals leads to cooperation between RXRα, RBPJ, STAT5, and SMAD4 for the transcriptional and epigenetic regulation of key AM-core genes. These results underscore the role of RXRs as key TFs that cooperate with other regulatory elements to establish the AM population and determine AM identity., This work was supported by grants to M. Ricote: S2022/BMD-7227 Comunidad de Madrid, PID2021-122552OB-I00, PID2024-155614OB-I00, and CNS2023-143622 funded by Ministerio de Ciencia e Innovación (MICIN)/Agencia Estatal de Investigación (AEI)/10.13039/501100011033 and by European Regional Development Fund (ERDF), European Union, and European Union NextGenerationEU/PRTR; grant PID2022-142616OB-I00 funded by Ministerio de Ciencia, Innovación y Universidades (MICIU)/AEI/10.13039/501100011033 and by ERDF, European Union, to T. Fischer and PID2021-123044OB-I00 MICIN/AEI to C. Casals. J. Mínguez-Martínez was supported by an PRE2019-087964 fellowship funded by MICIU, J. Porcuna by an FPU17/01731 fellowship funded by Ministerio de Educación, Cultura y Deporte (MECD), and L. Casablanca by an PRE2022-101483 fellowship funded by MICIN. The CNIC is supported by the Instituto de Salud Carlos III, the MICIN, and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033). Centro Nacional de Biotecnología is a Severo Ochoa Center of Excellence (CEX2023-001386-S funded by MICIN/AEI/10.13039/501100011033). Open Access funding provided by Consejo Superior de Investigaciones Científicas., Peer reviewed, Modelo experimental animal, Mamíferos - Roedores
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mitochondrial complex I activity promotes antigen cross-presentation in dendritic cells

  • Khouili, Sofía C
  • Priego, Elena
  • Heras-Murillo, Ignacio
  • Dunphy, Gillian
  • Mastrangelo, Annalaura
  • Martínez-Cano, Sarai
  • Nuñez, Vanessa
  • Rodrigo-Tapias, Manuel
  • Belinchón-García, Adrián
  • Garaude, Johan
  • Iborra, Salvador
  • Chandel, Navdeep S
  • González-Rodríguez, Patricia
  • Enamorado, Michel
  • Sancho, David
[Data, Code, and Materials Availability] Sequencing data have been deposited in GEO under accession number GSE325287. Metabolomics data have been deposited in Metabolomics Workbench under accession number ST004768. Tabulated data underlying the figures are provided in data file S1, and uncropped immunoblots are provided in data file S2. All other data needed to support the conclusions of the paper are present in the paper or the Supplementary Materials. No custom code was generated. All materials are commercially available as described in Materials and Methods., Mitochondrial metabolism modulates immune cell signaling, yet how individual electron transport chain complexes fine-tune dendritic cell (DC) function remains unclear. Here, we identify mitochondrial complex I (CI) as a critical metabolic checkpoint controlling antigen cross-presentation by DCs in mice. Deficiency of the CI subunit NDUFS4 in DCs led to the formation of a nonfunctional CI subcomplex, resulting in mildly impaired mitochondrial respiration without triggering a compensatory glycolytic shift. NDUFS4 deficiency limited endosomal escape of internalized antigens, thereby impairing antigen cross-presentation while largely preserving direct presentation. CI dysfunction lowered the NAD+/NADH ratio, concomitant with decreased ATP levels, and diminished neutral lipid storage and lipid peroxidation. Restoration of the NAD+/NADH ratio rescued cross-presentation in NDUFS4-deficient DCs. NDUFS2-deficient DCs showed similar defects in cross-presentation, which were also rescued by rebalancing the NAD+/NADH ratio. Together, these findings reveal a link between mitochondrial CI integrity, NAD+-driven redox metabolism, and antigen cross-presentation., [Editor's summary] Cross-presentation of extracellular antigens by dendritic cells (DCs) is a specialized function critical for eliciting CD8 T cell responses against viral and tumor antigens. Khouili et al. show that mitochondrial complex I (CI) activity supports antigen endosomal escape and promotes efficient cross-presentation by conventional type 1 DCs (cDC1s). CI activity selectively in cDC1s was also necessary for optimal cross-priming of CD8 T cell responses during viral infection and tumor challenge. Loss of the CI subunit NDUFS4 or NDUFS2 disrupted DC redox homeostasis, whereas restoration of the NAD+/NADH ratio was sufficient to rescue cross-presentation capacity. These findings identify mitochondrial redox metabolism as a key regulator of antigen cross-presentation in DCs. —Claire Olingy, E.P. was funded by Contratos Predoctorales para la Formación de Doctores 2017 (Referencia: BES-2017-079717). Metabolomics Workbench (68) is supported by NIH grants U2C-DK119886 and OT2-OD030544. Work in the D.S. laboratory is funded by the CNIC; by Ministerio de Ciencia, Innovación y Universidades (MICIU) PID2022-137712OB-I00, PDC2025-165319-I00, CPP2022-009762, and CPP2024-011365 MICIU/AEI/10.13039/501100011033 Agencia Estatal de Investigación, Unión Europea NextGenerationEU/PRTR; by the Comunidad de Madrid (P2022/BMD-7333 INMUNOVAR-CM); by the Scientific Foundation of the Spanish Association Against Cancer (AECC- PRYGN246642SANC); by the Worldwide Cancer Research WWCR-25-0080; by CRIS Foundation (excellence2025_03); and the by “la Caixa” Foundation (LCF/PR/HR23/52430012 and LCF/PR/HR22/52420019). Work in M.E.’s Laboratory is supported by a seed package from the Icahn School of Medicine at Mount Sinai (Sinai Cloud Fund #IS127201039). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the MICIU, and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (CEX2020-001041-S funded by MICIU/AEI /10.13039/501100011033)., With funding form the Spanish government through the "Severa Ochoa Centre of Excellence" accreditation (CEX2020-001041-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Targeting of ibrutinib resistance-driving pathways by miR-28 in ABC-DLBCL

  • Álvarez-Corrales, Emigdio
  • Moreno-Palomares, Rocío
  • Gómez-Escolar, Carmen
  • Martínez, Mario
  • Moral-Pérez, Udane
  • Laguna-Herrero, María
  • Fuertes, Teresa
  • Estrada, Belén S.
  • Mur, Sonia
  • Bonis, Adriana de
  • Leiva, Magdalena
  • Martínez-Martín, Nuria
  • Somoza, Álvaro
  • Ramiro, Almudena R.
  • Yébenes, Virginia G. de
The RNA-seq datasets generated during the current study are available in the ArrayExpress Functional Genomics Data repository (accession number: E-MTAB-16241)., Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive B-cell lymphoma. Although many patients respond well to R-CHOP immunochemotherapy, those with the activated B-cell (ABC) subtype are often refractory or relapse. Bruton tyrosine kinase (BTK) inhibitors such as ibrutinib have improved outcomes, but acquired resistance limits their long-term efficacy. Here, we modeled the development of ibrutinib resistance in ABC-DLBCL and investigated whether the BCR-signaling regulator microRNA-28 (miR-28) can block this process. Using flow cytometry-based competition assays, multicolor clonal barcoding, transcriptomic profiling, and xenograft models, we found that miR-28 expression impairs the emergence of ibrutinib-resistant ABC-DLBCL cells. Mechanistically, miR-28 interferes with the clonal selection process triggered by ibrutinib treatment and rewires transcriptional programs by downregulating mitochondrial and mTOR signaling pathways critical for resistance development. Furthermore, the miR-28-repressed gene signature associated with ibrutinib resistance correlates with improved survival in ibrutinib-treated patients from the PHOENIX trial cohort with the MCD genetic subtype, which is associated with ABC-DLBCL. Finally, the targeted therapeutic delivery of miR-28 via aptamer-guided nanoparticles suppresses ibrutinib-resistant tumor growth in vivo. These findings identify miR-28 as an effective inhibitor of ibrutinib resistance, underscoring its translational potential as an adjunct strategy in ABC-DLBCL therapy., We thank Janssen and the European Genome-phenome Archive for providing access to data from the PHOENIX trial, the members of the B cell biology lab, Balbino Alarcón, José Luis Marina, and María Jesús García de Yébenes for helpful discussions, and Arantzazu Alfranca for providing the LeGO vectors. E.A.C. and R.M.P were supported by PhD fellowships from the Comunidad de Madrid (PIPF-2022/SAL-GL-24469 and PIPF-2023/SAL-GL-29484 respectively), A.R.R. by CNIC funding and V.G.Y. by the Universidad Complutense de Madrid. B.S.E. is supported by a FPI contract from the Spanish Ministry of Science (PRE2022-102696). This work was funded by Spanish Ministerio de Ciencia e Innovación grants PID2019-107551RB-I00/AEI/10.13039/501100011033 and PID2022-137014OB-I00/AEI/10.13039/501100011033/ FEDER, UE to V.G.Y and PID2023-146982OB-I00, CEX2020-001039-S and PID2024-159895OB-100 to A.S, IMDEA Nanociencia and M.L, respectively. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation), and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033). N.M.M. lab is supported by the grants CNS2022-135636, PID2021-126298OB-I00, PID2024-162320OB-I00 (founded by MCIU/AEI/10.13039/501100011033/FEDER, UE) and HR22-00447 (founded by La Caixa)., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2020-001039-S), With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2020-001041-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and Are Clinically Relevant across Central Nervous System Disorders

  • Alvaro-Espinosa, Laura
  • Marquez-Galera, Angel
  • Priego, Neibla
  • García-Calvo, Virginia
  • Perea-García, Maria
  • Hernandez-Oliver, Carolina
  • Retana, Diana
  • Sanchez, Oliva
  • Pablos-Aragoneses, Ana de
  • García-Gómez, Pedro
  • Graña-Castro, Osvaldo
  • Lapuente-Santana, Óscar
  • Serrano-Ron, Laura
  • Al-Shahrour, Fatima
  • Cayuela López, Ana
  • Peset, Isabel
  • Megías, Diego
  • Ola, Mihaela
  • Varešlija, Damir
  • Young, Leonie S.
  • Martí-Mateos, Yolanda
  • Enríquez, Jose A.
  • Hernández-Encinas, Elena
  • Blanco-Aparicio, Carmen
  • Soengas, María S.
  • Bernhagen, Juergen
  • Antón-Fernández, Alejandro
  • Ávila, Jesús
  • Marchena, Miguel A.
  • Torres, Maximiliano
  • Castro Soubriet, Fernando de
  • Márquez-Ropero, Mar
  • Sierra, Amanda
  • López-Atalaya, José P.
  • Valiente, Manuel
  • RENACER Group
The upregulation of CD74, a chaperone involved in MHC-II antigen processing, has been mostly interpreted as indicative of antigen presentation in multiple brain disorders. However, CD74 expression has also been described in cancer cells across multiple tumor types and in the tumor microenvironment, notably in glioma. In this study, we found that the presence of CD74+ microglia/macrophages, which was induced by increased levels of interferon γ in brains affected by metastases, did not relate to its canonical pathway. Instead, the alternative function of CD74 as a cytokine receptor was pivotal. Proliferating cancer cells produced high levels of the ligand migration inhibitory factor (MIF) that bound the CD74 receptor and induced its translocation to the nucleus where it activated an NF-κB-dependent program that promoted metastatic progression. In patients, a CD74 signature was associated with more aggressive progression of brain metastatic disease, although it had no clinical correlation with the matched primary tumor. Interestingly, a pan-disease noncanonical and clinically relevant signature derived from the CD74+ myeloid population was identified that occurred in additional brain disorders, including Alzheimer's disease and multiple sclerosis. The brain-penetrant drug ibudilast, which prevents the binding of MIF to CD74, decreased brain metastasis in experimental models in vivo and in patient-derived organotypic cultures ex vivo in a primary tumor-agnostic manner. These findings suggest that MIF/CD74-induced reprogramming of myeloid cells in brain disorders is a vulnerability that could be exploited therapeutically against brain metastases and possibly other brain disorders., We thank all members of the Brain Metastasis Group for critical discussion of the manuscript; the CNIO Core Facilities for their excellent assistance; and Estefanía Sánchez-Jiménez (F. de Castro laboratory at Instituto Cajal-CSIC) and the staff at the Animal Facilities of the Instituto Cajal-CSIC for their extraordinary help with animals of the cuprizone demyelinating murine model of multiple sclerosis. Special thanks to patients and their families who donated valuable materials to RENACER and all site personnel, investigators, funders, and industry partners who supported the generation of the data within this study. Postmortem cortical brain tissue blocks from patients with multiple sclerosis and controls, as well as the associated clinical and neuropathologic data, were supplied by the Multiple Sclerosis & Parkinson’s Tissue Bank at Imperial College (London, United Kingdom), funded by the Multiple Sclerosis Society of Great Britain and Northern Ireland, registered charity 207495. We thank J. Massagué (MSKCC) for some of the BrM cell lines. This study was funded by La Marató (201906-30-31-32; M. Valiente), MICIU (SAF2017-89643-R, SAF2014-57243-R, and SAF2015-62547-ERC to M. Valiente; PID2022-143110OB-I00 and RED2024-153909-E to F. de Castro), H2020-FETOPEN (828972; M. Valiente), Bristol Myers Squibb MRA Young Investigator Award (498103; M. Valiente), Cancer Research Institute (Clinic and Laboratory Integration Program CRI Award 2018; 54545; M. Valiente), LAB AECC 2019 (LABAE19002VALI; M. Valiente), AECC Coordinados (PRYCO234528VALI; M. Valiente), ERC CoG (864759; M. Valiente), and ERANET-TRANSCAN-3 (TRANSCAN2021-203; M. Valiente) with funds from Instituto de Salud Carlos III/NextGenerationEU/PRTR (AC20/00114) and FC AECC (TRNSC213878VALI), CaixaResearch Health (HR23-00051; M. Valiente), MINECO-Ramón y Cajal (RYC-2013-13365; M. Valiente), MICIU/AEI/10.13039/501100011033 and ERDF (RTI2018-102260-B-I00; J.P. Lopez-Atalaya), Generalitat Valenciana (PROMETEO/2020/007; J.P. Lopez-Atalaya), Ramón Areces Foundation (CIVP20S10662 to E. Ortega-Paino/M.-J. Artiga; CIVP19S8163 to M. Valiente; and CIVP19A5917 to F. de Castro), Spanish Ministry of Science and Innovation Competitiveness MCIN/AEI/10.13039/501100011033 and “ERDF A way of making Europe” (RTI2018-099267-B-I00 and PID2022-136698OB-I00; A. Sierra), Basque Government grants (IT1473-22; A. Sierra), Alzheimer Association award (AARG-NTF-24-1304352; A. Sierra), Breast Cancer Ireland (18239A01; L.S. Young), Research Ireland (19/FFP/6443; L.S. Young, 20/FFP-P/8597; D. Varešlija, and 23/SPP/11783; L.S. Young, D. Varešlija), Breast Cancer Now (2021 July PCC1460; L.S. Young, D. Varešlija, 2019 Aug SF1310 with the generous support of Walk the Walk; D. Varešlija), MCIN/AEI/10.13039/501100011033 and the European Union “NextGenerationEU”/Plan de Recuperación Transformación y Resiliencia, PRTR (RTI2018-099357-B-I00, PID2021-1279880B, and TED2021-131611B-I00; J.A. Enríquez), CIBERFES (CB16/10/00282; J.A. Enríquez), Foundation Leducq (17CVD04; J.A. Enríquez), MCIN/AEI/10 PID2023-147213OB-I00 (M.S. Soengas), ERC-Advanced Grant 884699 (M.S. Soengas), La Caixa International PhD Program Fellowship-Marie Sklodowska-Curie (LCF/BQ/DI17/11620028; P. García-Gómez and LCF/BQ/DI19/11730044; A. de Pablos-Aragoneses), AECC postdoctoral fellowship (POSTD19016PRIE; N. Priego), MINECO-Severo Ochoa PhD Fellowship (BES-2017-081995; L. Alvaro-Espinosa), FPI-Severo Ochoa Fellowship PRE2018-083478 awarded by MICIU/AEI/10.13039/501100011033, and European Social Funds (FSE invierte en tu futuro; Y. Martí-Mateos). M. Valiente is an EMBO YIP member (4053). The CNIC is supported by the Instituto de Salud Carlos III, the Ministerio de Ciencia, Innovación y Universidades, and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIU/AEI/10.13039/501100011033). The Instituto de Neurociencias is a “Centre of Excellence Severo Ochoa” (CEX2021-001165-S funded by MCIU/AEI/10.13039/501100011033). CNIO is supported by the ISCIII, the Ministerio de Ciencia e Innovación, and is a Severo Ochoa Center of Excellence (SEV-2015-0510)., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2020-001041-S), With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001165-S), Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Clustering of lifestyle behaviors and adiposity in early adolescents in Spain: findings from the SI! Program for Secondary Schools

  • Bodega, Patricia
  • Santos-Beneit, Gloria
  • Cos-Gandoy, Amaya de
  • Moreno, Luis A.
  • Miguel, Mercedes de
  • Orrit, Xavier
  • Tresserra-Rimbau, Anna
  • Martínez-Gómez, Jesús
  • Ramírez-Garza, Sonia L.
  • Laveriano-Santos, Emily P.
  • Arancibia-Riveros, Camila
  • Estruch, Ramón
  • Lamuela-Raventós, Rosa M.
  • Fernández-Jiménez, Rodrigo
  • Fernández-Alvira, Juan M..
Background Several unhealthy lifestyle behaviors in adolescence are often linked to overweight/obesity. Some of them may be present simultaneously, leading to combined effects on health. Therefore, the clustering of several unhealthy behaviors in adolescents might be associated with adiposity excess. Purpose To identify lifestyle patterns and analyze their association with adiposity in early adolescents. Methods A cross-sectional cluster analysis was performed in 1183 adolescents (50.5% girls) with a mean age of 12.5 (0.4) years included in the SI! Program for Secondary Schools in Spain to identify lifestyle patterns based on healthy diet, step counts, sleep time, and leisure screen time. Generalized mixed models were applied to estimate the association between lifestyle patterns and adiposity indices. Results Four lifestyle patterns were derived: Cluster 1-higher screen time and poorer diet (n = 213), Cluster 2-lower activity and longer sleepers (n = 388), Cluster 3-active and shorter sleepers (n = 280), and Cluster 4-healthiest (n = 302). Except for the number of steps (12,008 (2357) day), the lifestyle behaviors in our sample presented levels far below the recommendations, especially for sleep duration. Cluster 4 included the largest proportion of adolescents from high socioeconomic status families (47.7%) and the lowest prevalence of overweight/obesity (23.1%). Compared to Cluster 4-healthiest, adolescents in the remaining clusters presented a higher prevalence of overweight/obesity and central obesity, showing Cluster 3 the highest prevalences (PR:1.31 [95%CI: 1.31, 1.31] and PR:1.40 [95%CI: 1.33, 1.47]). Conclusions Clustering of lifestyle patterns in early adolescence allows the identification of individuals with excess adiposity, in whom health promotion strategies should be stressed, especially in socioeconomically disadvantaged groups. Trial registration Clinical Trial Registry, NCT03504059. Registered 20/04/2018—Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT03504059.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Shaping current European mitochondrial haplogroup frequency in response to infection: the case of SARS-CoV-2 severity

  • Cabrera-Alarcon, José Luis
  • Cruz, Raquel
  • Rosa-Moreno, Marina
  • Latorre-Pellicer, Ana
  • de Almeida, Silvia Diz
  • Abellan, Javier
  • Acosta-Isaac, René
  • Aguado, Jose María
  • Aguilar, Carlos
  • Aguilera-Albesa, Sergio
The frequency of mitochondrial DNA haplogroups (mtDNA-HG) in humans is known to be shaped by migration and repopulation. Mounting evidence indicates that mtDNA-HG are not phenotypically neutral, and selection may contribute to its distribution. Haplogroup H, the most abundant in Europe, improved survival in sepsis. Here we developed a random forest trained model for mitochondrial haplogroup calling using data procured from GWAS arrays. Our results reveal that in the context of the SARS-CoV-2 pandemic, HV branch were found to represent protective factors against the development of critical SARS-CoV-2 in an analysis of 14,349 patients. These results highlight the role of mtDNA in the response to infectious diseases and support the proposal that its expansion and population proportion has been influenced by selection through successive pandemics.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Trajectories of adherence to an obesogenic dietary pattern and changes in diet quality, food intake, and adiposity during adolescence

  • Martínez-Gómez, Jesús
  • Bodega, Patricia
  • Santos-Beneit, Gloria
  • de Cos-Gandoy, Amaya
  • Beneito-Durá, María
  • de Miguel, Mercedes
  • Tresserra-Rimbau, Anna
  • Ruiz-León, Ana María
  • Estruch, Ramón
  • Lamuela-Raventós, Rosa María
  • Moreno, Luis A.
  • Fernández-Alvira, Juan Miguel
  • Fernández-Jiménez, Rodrigo
Background and Aims Contemporary longitudinal data on dietary patterns (DP) during adolescence are scarce. This study aimed to identify trajectories of adherence to an obesogenic DP and changes in diet quality (DQ), related food consumption, and adiposity markers during adolescence. Methods A cohort of 600 adolescents (293 girls, 48.8%) attending 24 secondary schools enrolled on the SI! Program for Secondary Schools trial in Spain was assessed when participants were approximately 12, 14, and 16 years old. An energy-dense, high-fat, and low-fiber (obesogenic) DP was derived at each time point by reduced rank regression (RRR) using the percentage energy intake from fat, fiber density, and dietary energy density as intermediate variables. Based on each participant's resulting scores, trajectories of adherence to the obesogenic DP were identified by latent class trajectory modeling. Adjusted associations between trajectories, DQ and food consumption changes, and adiposity markers during adolescence were analyzed with generalized linear models. Results Based on adherence to the obesogenic DP during adolescence, four stable trajectory groups (from lowest to highest adherence) were identified: trajectory 1 (44 participants [7.3%]), trajectory 2 (180 participants [30.0%]), trajectory 3 (292 participants [48.7%]), and trajectory 4 (84 participants [14.0%]). Overall DQ was moderate, but showed a gradient across trajectories, with trajectory 1 having the best quality. Although the identified trajectories were stable, individuals in the group with the lowest adherence to the obesogenic DP (trajectory 1) significantly improved their overall DQ over time, whereas those with the highest adherence (trajectory 4) showed the opposite trend. The group of adolescents in trajectory 4 had the least healthy central adiposity profile when ∼16 years old. Conclusion Four stable trajectories of adherence to an obesogenic DP were identified in a large cohort of adolescents, with DQ decreasing as adherence to the DP increased. Although adherence to the DP was stable, differences in food intake between trajectories widened over time, resulting in increased central adiposity in participants with the highest adherence to the pattern at the end of the study. Further research is needed to explore the determinants of adherence to obesogenic DPs in adolescence and to evaluate their effects on adiposity and overall health later in life.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Body image satisfaction, food consumption, diet quality, and emotional management in adolescence: a longitudinal analysis from the SI! program for secondary schools trial

  • Bodega, Patricia
  • Fernández-Alvira, Juan M.
  • de Cos-Gandoy, Amaya
  • Moreno, Luis A.
  • de Miguel, Mercedes
  • Rodríguez, Carla
  • Martínez-Gómez, Jesús
  • Laveriano-Santos, Emily P.
  • Castro-Barquero, Sara
  • Estruch, Ramón
  • Lamuela-Raventós, Rosa M.
  • Fernández-Jiménez, Rodrigo
  • Santos-Beneit, Gloria
Background: Adolescence involves physical and psychological changes that often conflict with body ideals, potentially increasing body image (BI) dissatisfaction and unhealthy diet. The main objective was to analyze cross-sectional and longitudinal associations between BI satisfaction (BIS) and nutritional status, dietary habits (DH), and emotional management (EM) in adolescents. Methods: 1315 adolescents from the SI! Program for Secondary Schools trial reported their BIS, DH, and EM at ages 12, 14 and 16. Linear and logistic mixed models estimated the associations between BIS, food intake, diet quality, and EM. Linear and logistic mixed-effect models for repeated measures assessed mean change estimates from baseline to 2- and 4-year follow-up in food intake and EM, stratified by gender. Results: A large proportion of adolescents without excess weight were dissatisfied with their BI. BIS was significantly associated with DH, especially in boys. Body-satisfied adolescents at baseline tended to have healthier DH (diet quality index: boys 56.7 ± 13.0; girls 58.8 ± 12.7) and showed a greater improvement in diet quality at 16 years (boys 3.44 (1.50, 5.37); girls 1.85 (0.18, 3.52)). Adolescents who desired to lose weight decreased their intake of sugar-sweetened beverages, sweets, and snacks, whereas boys who desired to gain weight consumed more frequently fast food, sweets, snacks, and processed meat. Body-satisfied adolescents had higher self-esteem, and girls desiring to gain weight presented higher emotional eating. Conclusions: BIS was associated with nutritional status, and EM, showing gender differences. Overall, the desire to gain weight was associated with unhealthier DH. Educational interventions should promote self-esteem and BIS by focusing messages on healthy eating instead of body weight.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Titin domains with reduced core hydrophobicity cause dilated cardiomyopathy

  • Martínez-Martín, Inés
  • Crousilles, Audrey
  • Ochoa, Juan Pablo
  • Velázquez-Carreras, Diana
  • Mortensen, Simon A.
  • Herrero-Galán, Elías
  • Delgado Blanco, Javier
  • Domínguez, Fernando
  • García-Pavía, Pablo
  • Sancho, David de
  • Wilmanns, Matthias
  • Alegre-Cebollada, Jorge
The underlying genetic defect in most cases of dilated cardiomyopathy (DCM), a common inherited heart disease, remains unknown. Intriguingly, many patients carry single missense variants of uncertain pathogenicity targeting the giant protein titin, a fundamental sarcomere component. To explore the deleterious potential of these variants, we first solved the wild-type and mutant crystal structures of I21, the titin domain targeted by pathogenic variant p.C3575S. Although both structures are remarkably similar, the reduced hydrophobicity of deeply buried position 3575 strongly destabilizes the mutant domain, a scenario supported by molecular dynamics simulations and by biochemical assays that show no disulfide involving C3575. Prompted by these observations, we have found that thousands of similar hydrophobicity-reducing variants associate specifically with DCM. Hence, our results imply that titin domain destabilization causes DCM, a conceptual framework that not only informs pathogenicity assessment of gene variants but also points to therapeutic strategies counterbalancing protein destabilization., J.A.-C. acknowledges funding from the Ministerio de Ciencia e Innovación (MCIN, MCIN/AEI/10.13039/501100011033) through grants BIO2017-83640-P (AEI/FEDER, EU), PID2020-120426GB-I00, and RED2022-134242-T and the Regional Government of Madrid (grant Tec4Bio S2018/NMT-4443, 50% co-financed by the European Social Fund and the European Regional Development Fund for the programming period 2014–2020). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the MCIN, and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MCIN). I.M.-M. holds a fellowship from 'la Caixa' Foundation (ID 100010434, fellowship code LCF/BQ/DR20/11790009) and received support from a Erasmus + Training fellowship. Financial support to D.d.S. comes from Eusko Jaurlaritza (Basque Government) through the project IT1584-22 and from the MCIN through grants PID2021-127907NB-I00 (AEI/FEDER, UE) and RYC-2016-19590 (AEI/FSE, EU). We thank Maria Rosaria Pricolo for analysis support with database analysis, Vytautas Gapsys for his assistance using the pmx software package, and the staff at the DIPC Supercomputing Center and the Sample Preparation and Characterization facility of the EMBL Hamburg Unit for technical support. The synchrotron data were collected at beamline operated by EMBL Hamburg at the PETRA III storage ring (DESY, Hamburg, Germany). We thank the Spectroscopy and Nuclear Magnetic Resonance Core Unit at CNIO for access to CD instrumentation. Biorender.com was used as a source for icons included in some of the figures of this paper.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Exercise and tumor proteome: insights from a neuroblastoma model

  • González Gálvez, Beatriz
  • Martín Ruiz Valdepeñas, María Asunción
  • Plaza-Florido, Abel
  • López, Juan A.
  • Santos-Lozano, Alejandro
  • Zazo, Sandra
  • Rincón-Castanedo, Cecilia
  • Lumbreras, Jorge
  • Terrón-Camero, Laura C.
  • López-Soto, Alejandro
  • Andrés-León, Eduardo
  • González-Murillo, África
  • Rojo, Federico
  • Ramírez, Manuel
  • Lucía, Alejandro
  • Fluza-Luces, Carmen
The impact of exercise on pediatric tumor biology is essentially unknown. We explored the effects of regular exercise on tumor proteome profile (as assessed with liquid chromatography with tandem mass spectrometry) in a mouse model of one of the most aggressive childhood malignancies, high-risk neuroblastoma (HR-NB). Tumor samples of 14 male mice (aged 6-8 wk) that were randomly allocated into an exercise (5-wk combined aerobic and resistance training) or nonexercise control group (6 and 8 mice/group, respectively) were analyzed. The Search Tool for the Retrieval of Interacting Genes/Proteins database was used to generate a protein-protein interaction (PPI) network and enrichment analyses. The Systems Biology Triangle (SBT) algorithm was applied for analyses at the functional category level. Tumors of exercised mice showed a higher and lower abundance of 101 and 150 proteins, respectively, than controls [false discovery rate (FDR) < 0.05]. These proteins were enriched in metabolic pathways, amino acid metabolism, regulation of hormone levels, and peroxisome proliferator-activated receptor signaling (FDR < 0.05). The SBT algorithm indicated that 184 and 126 categories showed a lower and higher abundance, respectively, in the tumors of exercised mice (FDR < 0.01). Categories with lower abundance were involved in energy production, whereas those with higher abundance were related to transcription/translation, apoptosis, and tumor suppression. Regular exercise altered the abundance of hundreds of intratumoral proteins and molecular pathways, particularly those involved in energy metabolism, apoptosis, and tumor suppression. These findings provide preliminary evidence of the molecular mechanisms underlying the potential effects of exercise in HR-NB. NEW & NOTEWORTHY We used liquid chromatography with tandem mass spectrometry to explore the impact of a 5-wk exercise intervention on the tumor proteome profile in a mouse model of one of the most aggressive childhood malignancies, high-risk neuroblastoma. Exercise altered the abundance of hundreds of proteins and pathways, particularly those involved in energy metabolism and tumor suppression. These molecular changes could mediate, at least partly, the potential antitumorigenic effects of exercise.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF), a double blind, placebo-controlled, randomized clinical trial

  • García-Álvarez, Ana|||0000-0002-1718-2424
  • Blanco, Isabel|||0000-0001-9452-3432
  • García-Lunar, Inés
  • Jordà, Paloma|||0000-0002-9236-1713
  • Rodriguez-Arias, Juan J.
  • Fernández-Friera, Leticia
  • Zegrí-Reiriz, Isabel|||0000-0001-9742-8537
  • Nuche, Jorge
  • Gomez-Bueno, Manuel
  • Prat, Susanna
  • Pujadas, Sandra|||0000-0001-5232-4865
  • Solé González, Eduard|||0000-0002-5727-9925
  • Garcia-Cossio, Maria D.
  • Rivas, Mercedes
  • Torrecilla, Estefanía
  • Pereda, Daniel
  • Sánchez González, Javier|||0000-0003-1427-3870
  • García-Pavía, Pablo|||0000-0002-5470-2257
  • Segovia, Javier|||0000-0002-4606-3416
  • Delgado-Jiménez, Juan Francisco|||0000-0002-5401-8324
  • Mirabet Pérez, Sonia|||0000-0001-5955-2748
  • Fuster, Valentín
  • Barberà i Mir, Joan Albert|||0000-0003-1469-4990
  • Ibañez, Borja|||0000-0002-5036-254X
Aims: Pulmonary hypertension (PH) associated with left heart disease is an increasingly prevalent problem, orphan of targeted therapies, and related to a poor prognosis, particularly when pre- and post-capillary PH combine. The current study aimed to determine whether treatment with the selective β3 adrenoreceptor agonist mirabegron improves outcomes in patients with combined pre- and post-capillary PH (CpcPH). Methods and results: The β3 Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure (SPHERE-HF) trial is a multicentre, randomized, parallel, placebo-controlled clinical trial that enrolled stable patients with CpcPH associated with symptomatic heart failure. A total of 80 patients were assigned to receive mirabegron (50 mg daily, titrated till 200 mg daily, n = 39) or placebo (n = 41) for 16 weeks. Of them, 66 patients successfully completed the study protocol and were valid for the main analysis. The primary endpoint was the change in pulmonary vascular resistance (PVR) on right heart catheterization. Secondary outcomes included the change in right ventricular (RV) ejection fraction by cardiac magnetic resonance or computed tomography, other haemodynamic variables, functional class, and quality of life. The trial was negative for the primary outcome (placebo-corrected mean difference of 0.62 Wood units, 95% confidence interval [CI] -0.38, 1.61, p = 0.218). Patients receiving mirabegron presented a significant improvement in RV ejection fraction as compared to placebo (placebo-corrected mean difference of 3.0%, 95% CI 0.4, 5.7%, p = 0.026), without significant differences in other pre-specified secondary outcomes. Conclusions: SPHERE-HF is the first clinical trial to assess the potential benefit of β3 adrenergic agonists in PH. The trial was negative since mirabegron did not reduce PVR, the primary endpoint, in patients with CpcPH. On pre-specified secondary outcomes, a significant improvement in RV ejection fraction assessed by advanced cardiac imaging was found, without differences in functional class or quality of life.
Dipòsit Digital de Documents de la UAB
Publicación Estudio, informe, memoria (Report)

Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy

  • Maestro, Alba|||0000-0003-1785-3125
  • Vela, Paula
  • De Frutos, Fernando|||0000-0003-4350-3217
  • Mora, Nerea
  • Pomares, Antonia
  • González-Vioque, Emiliano
  • Briceño, Ana
  • Cabrera-Borrego, Eva|||0000-0003-2997-2391
  • Cobo-Marcos, M.|||0000-0002-9026-061X
  • Dominguez, Fernando
  • Gonzalez-Lopez, Esther
  • Segovia, Javier|||0000-0002-4606-3416
  • Lara-Pezzi, Enrique
  • García-Pavía, Pablo|||0000-0002-5470-2257
Transthyretin amyloid cardiomyopathy (ATTR-CM) is increasingly recognized as a cause of heart failure in the elderly. Although wild-type transthyretin amyloidosis is the most frequent form of ATTR-CM found in the elderly, hereditary transthyretin amyloidosis (ATTRv) can also occur. We sought to determine the prevalence of ATTRv among elderly ATTR-CM patients, identify predictors of ATTRv and evaluate the clinical consequences of positive genetic testing in this population. Prevalence of ATTRv in elderly ATTR-CM patients (≥70 years) was assessed in a cohort of 300 consecutive ATTR-CM patients (median age 78 years at diagnosis, 82% ≥70 years, 16% female, 99% Caucasian). ATTRv was diagnosed in 35 (12%; 95% confidence interval [CI] 3.1-8.8) and 13 (5.3%; 95% CI 5.6-26.7) patients in the overall cohort and in those ≥70 years, respectively. Prevalence of ATTRv among elderly female patients with ATTR-CM was 13% (95% CI 2.1-23.5). Univariate analysis identified female sex (odds ratio [OR] 3.66; 95% CI 1.13-11.85; p = 0.03), black ancestry (OR 46.31; 95% CI 3.52-Inf; p = 0.005), eye symptoms (OR 6.64; 95% CI 1.20-36.73; p = 0.03) and polyneuropathy (OR 10.05; 95% CI 3.09-32.64; p < 0.001) as the only factors associated with ATTRv in this population. Diagnosis of ATTRv in elderly ATTR-CM patients allowed initiation of transthyretin-specific drug treatment in 5 individuals, genetic screening in 33 relatives from 13 families, and identification of 9 ATTRv asymptomatic carriers. Hereditary transthyretin amyloidosis is present in a substantial number of ATTR-CM patients aged ≥70 years. Identification of ATTRv in elderly patients with ATTR-CM has clinical meaningful therapeutic and diagnostic implications. These results support routine genetic testing in patients with ATTR-CM regardless of age.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Retinal Pigment Epithelium-Secreted VEGF-A Induces Alpha-2-Macroglobulin Expression in Endothelial Cells

  • Lehmann, Guillermo L.
  • Ginsberg, Michael
  • Nolan, Daniel J.|||0000-0002-4913-0813
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Martínez-González, José|||0000-0002-3894-7166
  • Zeng, Shemin
  • Voigt, Andrew P.
  • Mullins, Robert F.|||0000-0002-5006-0891
  • Rafii, Shahin
  • Rodriguez-Boulan, Enrique
  • Benedicto, Ignacio
Alpha-2-macroglobulin (A2M) is a protease inhibitor that regulates extracellular matrix (ECM) stability and turnover. Here, we show that A2M is expressed by endothelial cells (ECs) from human eye choroid. We demonstrate that retinal pigment epithelium (RPE)-conditioned medium induces A2M expression specifically in ECs. Experiments using chemical inhibitors, blocking antibodies, and recombinant proteins revealed a key role of VEGF-A in RPE-mediated A2M induction in ECs. Furthermore, incubation of ECs with RPE-conditioned medium reduces matrix metalloproteinase-2 gelatinase activity of culture supernatants, which is partially restored after A2M knockdown in ECs. We propose that dysfunctional RPE or choroidal blood vessels, as observed in retinal diseases such as age-related macular degeneration, may disrupt the crosstalk mechanism we describe here leading to alterations in the homeostasis of choroidal ECM, Bruch's membrane and visual function.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

MDA-LDL vaccination induces athero-protective germinal-center-derived antibody responses

  • Martos-Folgado, Inmaculada
  • del Monte-Monge, Alberto
  • Lorenzo, Cristina
  • Busse, Christian E.
  • Delgado, Pilar
  • Mur, Sonia M.
  • Cobos-Figueroa, Laura
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Martín-Ventura, Jose L.
  • Wardemann, Hedda
  • Ramiro, Almudena R.|||0000-0002-7539-3844
Atherosclerosis is a chronic inflammatory disease of the arteries that can lead to thrombosis, infarction, and stroke and is the leading cause of mortality worldwide. Immunization of pro-atherogenic mice with malondialdehyde-modified low-density lipoprotein (MDA-LDL) neo-antigen is athero-protective. However, the immune response to MDA-LDL and the mechanisms responsible for this athero-protection are not completely understood. Here, we find that immunization of mice with MDA-LDL elicits memory B cells, plasma cells, and switched anti-MDA-LDL antibodies as well as clonal expansion and affinity maturation, indicating that MDA-LDL triggers a bona fide germinal center antibody response. Further, Prdm1 Aicda-Cre Ldlr pro-atherogenic chimeras, which lack germinal center-derived plasma cells, show accelerated atherosclerosis. Finally, we show that MDA-LDL immunization is not athero-protective in mice lacking germinal-center-derived plasma cells. Our findings give further support to the development of MDA-LDL-based vaccines for the prevention or treatment of atherosclerosis.
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Shaping current European mitochondrial haplogroup frequency in response to infection: the case ofSARS-CoV-2severity

  • Cabrera Alarcón, José Luis
  • Cruz, Raquel
  • Rosa Moreno, Marina
  • Latorre Pellicer, Ana
  • Diz de Almeida, Silvia
  • Scourge Cohort Group
  • Riancho, José A.
  • Rojas Martínez, Augusto
  • Flores, Carlos
  • Lapunzina, Pablo
  • Sánchez Cabo, Fátima
  • Carracedo, Ángel
  • Enriquez, José Antonio
Scourge Cohort Group: Javier Abellán, René Acosta-Isaac, Jose María Aguado, Carlos Aguilar, Sergio Aguilera-Albesa, Abdolah Ahmadi Sabbagh, Jorge Alba, Sergiu Albu, Karla A M Alcalá-Gallardo, Julia Alcoba-Florez, Sergio Alcolea Batres, Holmes Rafael Algarin-Lara, Virginia Almadana, Kelliane A Medeiros, Julia Almeida, Berta Almoguera, María R Alonso, Nuria Álvarez, Rodolfo Álvarez-Sala Walther, Yady Álvarez-Benítez, Felipe Álvarez-Navia, Katiusse A Dos Santos, Álvaro Andreu-Bernabeu, Maria Rosa Antonijoan, Eleno Martínez-Aquino, Eunate Arana-Arri, Carlos Aranda, Celso Arango, Carolina Araque, Nathalia K Araujo, Ana C Arcanjo, Ana Arnaiz, Francisco Arnalich Fernández, María J Arranz, José Ramón Arribas López, Maria-Jesús Artiga, Yubelly Avello-Malaver, Carmen Ayuso, Belén Ballina Martín, Raúl C Baptista-Rosas, Ana María Baldion, Andrea Barranco-Díaz, María Barreda-Sánchez, Viviana Barrera-Penagos, Moncef Belhassen-Garcia, David Bernal-Bello, Enrique Bernal, Joao F Bezerra, Marcos A C Bezerra, Natalia Blanca-López, Rafael Blancas, Lucía Boix-Palop, Alberto Borobia, Elsa Bravo, María Brion, Óscar Brochado-Kith, Ramón Brugada, Matilde Bustos, Alfonso Cabello, Alejandro Cáceres, Juan J Cáceres-Agra, Esther Calbo, Enrique J Calderón, Shirley Camacho, Francisco C Ceballos, Yolanda Cañadas, Cristina Carbonell, Servando Cardona-Huerta, María Sánchez-Carpintero Abad, Carlos Carpio-Segura, José Antonio Carrillo-Avila, Marcela C Campos, Carlos Casasnovas, Luis Castaño, Carlos F Castaño, Jose E Castelao, Aranzazu Castellano Candalija, María A Castillo, Walter G Chaves-Santiago, Sylena Chiquillo-Gómez, Marco A Cid-López, Óscar Cienfuegos-Jiménez, Rosa Conde-Vicente, Gabriela C R Cunha, M Lourdes Cordero-Lorenzana, Dolores Corella, Almudena Corrales, Jose L Cortés-Sánchez, Marta Corton, Karla S C Souza, Fabiola T C Silva, Raquel Cruz, Luisa Cuesta, Nathali A C Tavares, Maria C C Carvalho, David Dalmau, Raquel C S Dantas-Komatsu, M Teresa Darnaude, Raimundo de Andrés, Carmen de Juan, Juan J de la Cruz Troca, Carmen de la Horra, Ana B de la Hoz, Alba De Martino-Rodríguez, Marina S Cruz, Julianna Lys de Sousa Alves Neri, Victor Del Campo-Pérez, Juan Delgado-Cuesta, Aranzazu Diaz de Bustamante, Anderson Díaz-Pérez, Beatriz Dietl, Silvia Diz-de Almeida, Manoella do Monte Alves, Elena Domínguez-Garrido, Lidia S Rosa, Andre D Luchessi, Jose Echave-Sustaeta, Rocío Eiros, César O Enciso-Olivera, Gabriela Escudero, Pedro Pablo España, Gladys Estigarribia Sanabria, María Carmen Fariñas, Ramón Fernández, Lidia Fernández-Caballero, Ana Fernández-Cruz, Silvia Fernández-Ferrero, Yolanda Fernández Martínez, María J Fernandez-Nestosa, Uxía Fernández-Robelo, Amanda Fernández-Rodríguez, Marta Fernández-Sampedro, Ruth Fernández, Tania Fernández-Villa, Carmen Fernández-Capitán, Antonio Augusto F Carioca, Patricia Flores-Pérez, Lácides Fuenmayor-Hernández, Marta Fuertes-Núñez, Victoria Fumadó, Ignacio Gadea, Lidia Gagliardi, Manuela Gago-Domínguez, Natalia Gallego, Cristina Galoppo, Ana García-Soidán, Carlos García-Cerrada, Aitor García-de-Vicuña, Josefina Garcia-García, Irene García-García, Carmen García-Ibarbia, Andrés C García-Montero, Leticia García, Mercedes García, María Carmen García Torrejón, Inés García, Elisa García-Vázquez, Emiliano Garza-Frias, Angela Gentile, Belén Gil-Fournier, Jéssica N G de Araújo, Mario Gómez-Duque, Javier Gómez-Arrue, Luis Gómez Carrera, María Gómez García, Ángela Gómez Sacristán, Juan R González, Anna González-Neira, Beatriz González Álvarez, Fernán González Bernaldo de Quirós, Rafaela González-Montelongo, Javier González-Peñas, Manuel Gonzalez-Sagrado, Hugo Gonzalo-Benito, Oscar Gorgojo-Galindo, Miguel Górgolas, Florencia Guaragna, Jessica G Chaux, Encarna Guillén-Navarro, Beatriz Guillén-Guío, Pablo Guisado-Vasco, Luz D Gutiérrez-Castañeda, Juan F Gutiérrez-Bautista, Sara Heili-Frades, Rafael H Jacomo, Estefania Hernández, Cristina Hernández-Moro, Luis D Hernández-Ortega, Guillermo Hernández-Pérez, Rebeca Hernández-Vaquero, Belén Herráez, M Teresa Herranz, María Herrera, María José Herrero, Antonio Herrero-González, Juan P Horcajada, Natale Imaz-Ayo, Maider Intxausti-Urrutibeaskoa, Antonio Íñigo-Campos, María Íñiguez, Rubén Jara, Ángel Jiménez, Pilar Jiménez, María A Jiménez-Sousa, Iolanda Jordan, Ignacio Jiménez-Alfaro, Rocío Laguna-Goya, Daniel Laorden, María Lasa-Lázaro, María Claudia Lattig, Ailen Lauriente, Anabel Liger Borja, Lucía Llanos, Amparo López-Bernús, Miguel López de Heredia, Esther Lopez-Garcia, Eduardo López-Granados, Rosario Lopez-Rodriguez, Miguel A López-Ruz, Leonardo Lorente, José M Lorenzo-Salazar, José E Lozano, María Lozano-Espinosa, Ignacio Mahillo, Esther Mancebo, Carmen Mar, Cristina Marcelo Calvo, Alba Marcos-Delgado, Miguel Marcos, Alicia Marín-Candón, Pablo Mariscal-Aguilar, Laura Martin-Pedraza, Marta Martin-Fernandez, Caridad Martín-López, José-Ángel Martín-Oterino, María Dolores Martín, Vicente Martín, María M Martín, María Martín-Vicente, Amalia Martinez, Óscar Martínez-González, Ricardo Martínez, Pedro Martinez-Paz, Covadonga M Díaz-Caneja, Óscar Martínez-Nieto, Iciar Martínez-López, Michel F Martínez-Reséndez, Silvia Martínez, Juan José Martínez, Ángel Martínez-Pérez, Andrea Martínez-Ramas, Violeta Martínez-Robles, Laura Marzal, Juliana F Mazzeu, Francisco J Medrano, Xose M Meijome, Natalia Mejuto-Montero, Ingrid Mendes, Alice L Duarte, Ana Méndez-Echevarría, Humberto Mendoza Charris, Eleuterio Merayo Macías, Fátima Mercadillo, Arieh R Mercado-Sesma, Pablo Mínguez, Elena Molina-Roldán, Antonio J J Molina, Juan José Montoya, Susana M T Pinho, Patricia Moreira-Escriche, Xenia Morelos-Arnedo, Rocío Moreno, Víctor Moreno Cuerda, Antonio Moreno-Docón, Junior Moreno-Escalante, Alberto Moreno Fernández, Patricia Muñoz García, Pablo Neira, Julián Nevado, Israel Nieto-Gañán, Vivian N Silbiger, Rocío Nuñez-Torres, Antònia Obrador-Hevia, J Gonzalo Ocejo-Vinyals, Virginia Olivar, Silviene F Oliveira, Lorena Ondo, Alberto Orfao, Eva Ortega-Paino, Luis Ortega, Rocío Ortiz-López, Fernando Ortiz-Flores, José A Oteo, Manuel Pacheco, Fredy Javier Pacheco-Miranda, Irene Padilla-Conejo, Sonia Panadero-Fajardo, Mara Parellada, Roberto Pariente-Rodríguez, Vicente Friaza, Estela Paz-Artal, Germán Peces-Barba, Miguel S Pedromingo Kus, Celia Perales, Ney P C Santos, Genilson P Guegel, María Jazmín Pérez, Alexandra Pérez, Patricia Pérez-Matute, César Pérez, Gustavo Pérez-de-Nanclares, Felipe Pérez-García, Patricia Pérez, Luis A Pérez-Jurado, M Elena Pérez-Tomás, Teresa Perucho, Lisbeth A Pichardo, Adriana P Ribeiro, Mel Lina Pinsach-Abuin, Luz Adriana Pinzón, Jeane F P Medeiros, Guillermo Pita, Francesc Pla-Juncà, Laura Planas-Serra, Ericka N Pompa-Mera, Gloria L Porras-Hurtado, Aurora Pujol, María Eugenia Quevedo-Chávez, Maria Angeles Quijada, Inés Quintela, Soraya Ramiro-León, Pedro Rascado Sedes, Joana F R Nunes, Delia Recalde, Emma Recio-Fernández, Salvador Resino, Renata R Sousa, Carlos S Rivadeneira-Chamorro, Diana Roa-Agudelo, Montserrat Robelo Pardo, Marianne R Fernandes, María A Rodríguez-Hernández, Agustí Rodriguez-Palmero, Emilio Rodríguez-Ruiz, Marilyn Johanna Rodriguez, Fernando Rodríguez-Artalejo, Marena Rodríguez-Ferrer, Carlos Rodríguez-Gallego, José A Rodríguez-García, Belén Rodríguez Maya, Antonio Rodriguez-Nicolas, German Ezequiel Rodríguez-Novoa, Paula A Rodriguez-Urrego, Federico Rojo, Andrea Romero-Coronado, Rubén Morilla, Filomeno Rondón-García, Antonio Rosales-Castillo, Cladelis Rubio, María Rubio Olivera, Francisco Ruiz-Cabello, Eva Ruiz-Casares, Juan J Ruiz-Cubillan, Javier Ruiz-Hornillos, Montserrat Ruiz, Pablo Ryan, Hector D Salamanca, Lorena Salazar-García, Giorgina Gabriela Salgueiro-Origlia, Anna Sangil, Olga Sánchez-Pernaute, Pedro-Luis Sánchez, Antonio J Sánchez López, Clara Sánchez-Pablo, María Concepción Sánchez-Prados, Javier Sánchez-Real, Jorge Sánchez-Redondo, Cristina Sancho-Sainz, Esther Sande, Arnoldo Santos, Agatha Schlüter, Sonia Segovia, Alex Serra-Llovich, Fernando Sevil-Puras, Marta Sevilla-Porras, Miguel A Sicolo, Cristina Silván-Fuentes, Vitor M S Moraes, Vanessa S Souza, Jordi Solé-Violán, José Manuel Soria, Jose V Sorlí, Nayara S Silva, Juan Carlos Souto, John J Sprockel, José Javier Suárez-Rama, David A Suárez-Zamora, Xiana Taboada-Fraga, Eduardo Tamayo, Alvaro Tamayo-Velasco, Juan Carlos Taracido-Fernández, Romero H T Vasconcelos, Carlos Tellería, Thássia M T Carratto, Jair Antonio Tenorio-Castaño, Alejandro Teper, Izabel M T Araujo, Juan Torres-Macho, Lilian Torres-Tobar, Ronald P Torres-Gutiérrez, Jesús Troya, Miguel Urioste, Juan Valencia-Ramos, Agustín Valido, Juan Pablo Vargas-Gallo, Belén Varón, Tomas Vega, Santiago Velasco-Quirce, Valentina Vélez-Santamaría, Virginia Víctor, Julia Vidán-Estévez, Gabriela V Silva, Miriam Vieitez-Santiago, Carlos Vilches, Lavinia Villalobos, Felipe Villar, Judit Villar-Garcia, Cristina Villaverde, Pablo Villoslada-Blanco, Ana Virseda-Berdices, Tatiana X Costa, Zuleima Yáñez, Antonio Zapatero-Gaviria, Ruth Zarate, Sandra Zazo, Carlos Flores, José A Riancho, Augusto Rojas-Martinez, Pablo Lapunzina, Ángel Carracedo, The frequency of mitochondrial DNA haplogroups (mtDNA-HG) in humans is known to be shaped by migration and repopulation. Mounting evidence indicates that mtDNA-HG are not phenotypically neutral, and selection may contribute to its distribution. Haplogroup H, the most abundant in Europe, improved survival in sepsis. Here we developed a random forest trained model for mitochondrial haplogroup calling using data procured from GWAS arrays. Our results reveal that in the context of the SARS-CoV-2 pandemic, HV branch were found to represent protective factors against the development of critical SARS-CoV-2 in an analysis of 14,349 patients. These results highlight the role of mtDNA in the response to infectious diseases and support the proposal that its expansion and population proportion has been influenced by selection through successive pandemics., Agencia Estatal de Investigación, Centro de Investigación Biomédica en Red, Instituto de Salud Carlos III, Fundación Amancio Ortega Gaona, Banco de Santander S.A., Human Frontier Science Program, Leducq Foundation, European Regional Development Fund